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ABSTRACT 
 
Development of sensors for detection of various chemical and biological species 
is an important and ever-growing field. In particular, optical-based sensors enable a 
remote, rapid method for continuous or on-demand monitoring. Monitoring humidity is 
important across many applications, such as humidity control within moisture-sensitive 
environments and in medical, semiconductor, and food science fields. Following a study 
of photobleaching, defect-related emission of zinc oxide nanoparticles was monitored as 
a function of relative humidity. An important next step is its application to monitoring 
toxic gases, as air pollution has been identified as a major health concern. Of importance 
for the biomedical field is monitoring key blood analytes for human health. Monitoring 
blood pH is critical for specific patient groups, such as those suffering from diabetic 
ketoacidosis and congenital lactic acidosis. A pH-sensitive fluorophore was loaded 
within red blood cells for use as a continuous blood analyte monitor. Future work will 
focus on glucose, as current estimates show that one out of every three children born in 
2000 will develop diabetes in his or her lifetime – thus, the global impact of this disease 
is immense.  
Results from ZnO studies indicate that photobleaching is related to the surface 
area to volume ratio. ZnO nanoparticles display a linear response to humidity with a 
sensitivity of 0.008417 RH-1 and 0.01898 RH-1 for nitrogen and air environments, 
respectively. Owing to reversibility and high sensitivity, ZnO nanoparticles have great 
potential as optical-based environmental sensors.  
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Results from dye-loaded ghost studies indicate that fluorescence intensity of 
intracellular dyes report on extracellular pH. Resealed ghosts loaded with a fluorescein 
isothiocyanate-glycylglycine conjugate reversibly track pH with a resolution down to 
0.014 pH unit. For use in vivo, the development of an NIR pH-sensitive dye was 
paramount. Unfortunately, all NIR dyes tested exhibited poor pH sensitivity while 
displaying sensitivity to external factors (e.g., temperature, concentration, proteins). 
However, circulation kinetics of resealed ghosts were easily monitored once injected in 
vivo with an optical fiber-based system. Although the cells were rapidly removed from 
circulation, the loaded ghosts resulted in higher signal than would be expected for free 
dye alone. Once optimized, the resealed ghosts could serve as a long-term, continuous, 
circulating biosensor for the management of diseases. 
 iv 
 
DEDICATION 
 
I dedicate this work to my husband, Dustin, for his unfailing love and support 
throughout this entire process – I could not have done it without him at my side. It is an 
incredible blessing to have someone who understands exactly what I am going through 
and who knows what to say to make things clearer. Graduate school has given us 
opportunities we may never have had any other way. I am so happy that we were able to 
spend two months experiencing Rwanda – spending time with our host families, hiking a 
volcano (or for me, being dragged at least some of the way), working with our new 
BMET friends in the hospitals, soaking in the beauty of the savannah and rainforest, and 
spending many hours at the local coffee shops just enjoying the moment. We made 
memories we’ll always look back fondly on and never forget – I hope someday we make 
it back. Spending a week catching trains with you across Germany, Belgium, and the 
Netherlands was incredible – who knew we’d see so much of the world. And there is 
more yet to see. 
 
 
 v 
 
ACKNOWLEDGEMENTS 
 
I would first like to thank my advisor and mentor, Dr. Kenith Meissner, for his 
guidance and wisdom as it pertains to many things, but especially to research and 
teaching. He has always had an open door policy, and I certainly took advantage of it 
over the years. I would also like to thank him for his support in my first major teaching 
position and for guiding me when the path wasn’t clear. 
I would like to thank my committee members, Dr. Gerard Coté, Dr. Javier Jo, 
and Dr. Cristine Heaps for their time and support. I would also like to thank Dr. Coté for 
my first undergraduate research position years ago – he started me on a long path of 
research – as well as many good memories from Rwanda.  
Thank you to our colleagues, Dr. Tim Glass, Dr. Mark Milanick, Xiaole Shao, 
and Nicholas Cooley at the University of Missouri, for an exciting adventure on a really 
cool project. A special thank you to Dr. Milanick and his wife, Meg, for their hospitality 
during many visits. Also, a special thank you to Xiaole for synthesizing NIR dye I and to 
Nick for synthesizing NIR dye II, loading the ghosts for the in vivo work, and obtaining 
the corresponding microscopy images of the NIR dye-loaded ghosts.  
I would like to thank my colleagues in the Nanomaterials and Biophotonics Lab 
– Ravish Majithia, Sina Amini, Megan Poorman, Aishu Sooresh, Yilhwan You, and 
Sandra Bustamante Lopez – for making the years fly by. I would like to thank Yilhwan 
You for his assistance in obtaining the absorbance curve and Sandra Bustamante Lopez 
for her support in all red blood cell matters, particularly for assisting with the in vivo 
 vi 
 
work and obtaining confocal images of NIR dye-loaded bovine ghosts. I would like to 
thank Dr. Rosemary Walzem for use of the IR800 filter cube. I would also like to thank 
Dr. Stanislav Vitha at the Microscopy and Imaging Center facility at Texas A&M 
University. The Olympus FV1000 confocal microscope acquisition was supported by the 
Office of the Vice President for Research at Texas A&M University.  
Finally, I would like to thank my family: my parents, parents-in-law, 
grandparents, brother, sisters-in-law, and brother-in-law for their love, support, and 
patience. Thanks to each of you for supporting us in our trip to Africa – we could not 
have done it without you. A special thank you to my parents for always taking good care 
of their grand-dog, Jetta, when Dustin and I were out exploring other countries. Also, 
thank you for taking a chance and spending several weeks exploring the beauty and 
culture of Europe. I know that many things went wrong, but I was happy that you both 
visited and were able to see some of the things you always wanted to see, Mom.  
 
 vii 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT .......................................................................................................................ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
TABLE OF CONTENTS .................................................................................................vii 
LIST OF FIGURES ............................................................................................................ x 
LIST OF TABLES .......................................................................................................... xvi 
1. INTRODUCTION .......................................................................................................... 1 
1.1 Photoluminescence ................................................................................................... 1 
1.1.1 Fluorescence and Phosphorescence ................................................................... 1 
1.1.2 Semiconductor Luminescence ........................................................................... 3 
1.2 Photoluminescence-Based Sensing .......................................................................... 4 
1.2.1 Wavelength-Ratiometric Measurements for Luminescence Sensing ................ 5 
1.3 Unintended Sensitivity of Fluorophores to their Environment ................................ 5 
1.4 Outline of Dissertation ............................................................................................. 6 
2. APPLICATION OF ZINC OXIDE NANO- AND MICROSTRUCTURES TO 
OPTICAL HUMIDITY SENSING .................................................................................... 8 
2.1 Background .............................................................................................................. 8 
2.1.1 Zinc Oxide ......................................................................................................... 8 
2.1.2 Electrical-Based Sensing with ZnO .................................................................. 8 
2.1.3 ZnO Luminescence and Optical-Based Sensing ............................................... 9 
2.1.4 Clinical Relevance of ZnO for Monitoring NO2 and CO ................................ 10 
2.2 Materials and Methods ........................................................................................... 11 
2.2.1 Sample Preparation .......................................................................................... 11 
2.2.2 Optical System ................................................................................................ 12 
2.3 Results and Discussion ........................................................................................... 13 
2.3.1 ZnO Characterization ...................................................................................... 13 
2.3.2 Photobleaching Studies ................................................................................... 15 
2.3.3 Environmental Effects on ZnO Luminescence ............................................... 19 
2.3.4 Humidity Sensing ............................................................................................ 21 
 viii 
 
 Page 
2.3.4.1 Humidity sensing with nanopods and microrods ..................................... 23 
2.3.4.2 Humidity sensing with nanoparticles in nitrogen ..................................... 24 
2.3.4.3 Humidity sensing with nanoparticles in air .............................................. 26 
2.4 Conclusions ............................................................................................................ 28 
3. ENCAPSULATION OF FITC TO MONITOR EXTRACELLULAR PH: A STEP 
TOWARDS THE DEVELOPMENT OF RED BLOOD CELLS AS CIRCULATING 
BLOOD ANALYTE BIOSENSORS ............................................................................... 29 
3.1 Background ............................................................................................................ 29 
3.1.1 Clinical Relevance of Blood pH ...................................................................... 29 
3.1.2 Diabetes and Clinical Relevance of Blood Glucose ........................................ 30 
3.1.2.1 Electrochemical glucose monitoring ........................................................ 32 
3.1.2.2 Continuous glucose monitoring ............................................................... 33 
3.1.2.3 Nonelectrochemical glucose monitoring .................................................. 35 
3.1.3 Encapsulation within RBCs ............................................................................. 37 
3.1.4 RBCs ............................................................................................................... 40 
3.2 Materials and Methods ........................................................................................... 44 
3.2.1 Chemicals ........................................................................................................ 44 
3.2.2 Preparation of Dye-Loaded, Resealed Red Cell Ghosts .................................. 44 
3.2.3 Sensor Response and Spectral Data Acquisition ............................................. 45 
3.2.3.1 Optical system for dynamic data .............................................................. 46 
3.2.3.2 Optical system for static data ................................................................... 46 
3.2.3.3 In vivo data ............................................................................................... 47 
3.2.3.4 Testing of sensor integrity ........................................................................ 47 
3.3 Results and Discussion ........................................................................................... 48 
3.4 Conclusions ............................................................................................................ 55 
4. APPLICATION OF PH-SENSITIVE NIR DYES TOWARDS THE 
APPLICATION OF IN VIVO BLOOD ANALYTE SENSING ...................................... 57 
4.1 Background ............................................................................................................ 57 
4.1.1 Benefits of the NIR Region for In Vivo Systems – Biological Basis ............. 57 
4.1.2 Benefits of the NIR Region for In Vivo Systems – Optical System 
Components .............................................................................................................. 58 
4.2 Materials and Methods ........................................................................................... 58 
4.2.1 Preswelling Method for Loading Glycylglycine-FITC Conjugate into 
RBCs ........................................................................................................................ 58 
4.2.2 NIR-Based Benchtop Spectroscopy System ................................................... 59 
4.2.3 NIR-Based Portable Optical System ............................................................... 60 
4.2.4 In Vivo Experiments ....................................................................................... 62 
4.3 Results and Discussion ........................................................................................... 63 
 ix 
 
 Page 
4.3.1 Iteration 1, pH-Sensitive NIR Dye .................................................................. 63 
4.3.2 Iteration 2, pH-Sensitive NIR Dye .................................................................. 72 
4.3.3 In Vivo Implementation of NIR Dye II ........................................................... 80 
4.4 Conclusions ............................................................................................................ 94 
5. CONCLUSIONS .......................................................................................................... 96 
5.1 ZnO Nano/microstructures as Environmental Sensors .......................................... 96 
5.2 RBC-Based Monitoring of Blood Analytes ........................................................... 97 
REFERENCES ............................................................................................................... 100 
 
 x 
 
LIST OF FIGURES 
 
 Page 
Figure 1. Example Jablonski diagram displaying various photoluminescence 
processes with energy on the y-axis. Bold horizontal lines represent the 
ground vibrational states of the ground (S0) and excited singlet (S1 and S2) 
and triplet (T1) electronic energy states. The thinner horizontal lines are 
representative of vibronic energy levels corresponding to each electronic 
energy level. Radiative and nonradiative processes are designated with 
straight and wavy lines, respectively. ................................................................. 3 
Figure 2. Luminescence spectra of ZnO nanoparticles (dark blue) and microrods 
(light blue). Time-course luminescence data were integrated from 450 nm to 
690 nm, the defect-related band. ....................................................................... 15 
Figure 3. Recovery of ZnO nanoparticle luminescence following 20 min recovery 
period (blocked excitation). .............................................................................. 16 
Figure 4. (a) Percent photobleaching of ZnO samples following 30 sec of continuous 
excitation (1 mW, 350 nm). (b) Percent photobleaching of ZnO samples 
after 30 exposures of periodic excitation. Each 1 sec excitation is followed 
by either 5, 10, or 20 sec of recovery time during which the laser beam is 
blocked. ............................................................................................................. 17 
Figure 5. Percent of photobleaching following 30 sec of total excitation as a function 
of surface area to volume ratio due to 1 mW of (a) continuous excitation at 
350 nm and (b) periodic excitation at 350 nm using exposure schemes of 1 
sec excitation followed by recovery times of 5, 10 or 20 sec. .......................... 18 
Figure 6. Luminescence response to changes in excitation scheme in (a) dry nitrogen 
and (b) dry air. Grey areas represent segments of time during which the 
sample received continuous excitation. As indicated, the other regions are 
time periods of periodic excitation (left: 1 sec excitation followed by 20 sec 
recovery time, middle: 1 sec excitation followed by 10 sec recovery time, 
and right: 1 sec excitation followed by 5 sec recovery time). .......................... 21 
Figure 7. Luminescence of ZnO nanoparticles in different environments: (1) dry 
nitrogen; (2) ambient air; (3) humid nitrogen; (4) dry nitrogen; (5) ambient 
air; and (6) dry nitrogen. Ambient air, likely due to the presence of oxygen, 
results in an increase in luminescence. ............................................................. 22 
 
 xi 
 
 Page 
Figure 8. Representative response of ZnO microrods to changes between 0% RH and 
humidity levels of (a) 41% and (b) 71% RH in nitrogen. ................................. 24 
Figure 9. (a) Typical luminescence response of ZnO nanoparticles in response to a 10 
min dry nitrogen purge followed by a 20 min exposure to nitrogen with an 
increased humidity level and a 30 min purge with dry nitrogen. (b) Optical 
response of ZnO nanoparticles to various % RH levels. The curve follows a 
linear trend, with % change in optical signal increasing with increasing % 
RH. .................................................................................................................... 25 
Figure 10. Reversibility of the ZnO nanoparticle sensor was demonstrated by cycling 
between 0% RH nitrogen and greater than 90% RH nitrogen (grey regions). . 26 
Figure 11. (a) Response of ZnO nanoparticles to changes from 0% RH to 54% RH 
(dark blue) and 66% RH (light blue) in air. (b) Response of ZnO 
nanoparticles to changes in humidity within an air environment. .................... 27 
Figure 12. Cartoon illustrating the RBC sensing platform concept. A small portion of 
blood is removed from the patient; the blood is washed, loaded with the 
analyte-sensitive fluorescent dye, resealed, and then transfused back into the 
patient. An excitation light source is then directed at the wrist; the emission 
from the resealed red cell ghosts is collected and converted into an analyte 
concentration. Clip art used with permission from Microsoft. ......................... 38 
Figure 13. Comparison of fluorescence spectra of resealed ghosts (light blue) and free 
glycylglycine-FITC conjugate (dark blue) show that emission 
characteristics of the two solutions are nearly identical. .................................. 48 
Figure 14. A representative portion of a pH trial performed on the dynamic system. 
Fluorescence intensity (light blue) of the intracellular pH-sensitive dye 
(FITC) tracks extracellular pH (dark blue). ...................................................... 50 
Figure 15. Fluorescence intensity responds to pH changes using the static system in 
which extracellular glycylglycine-FITC conjugate fluorescence is quenched 
by the anti-fluorescein antibody. Each segment is the middle 15 sec of a 30 
sec fluorescence monitoring period. The grey lines indicate discontinuous 
data. The average pH is directly above each segment. ..................................... 51 
Figure 16. Normalized fluorescence intensity as a function of pH for the pH trials 
shown above in Figure 14 (○) and Figure 15 (●). The two trials agree well. 
Error bars represent one standard deviation. .................................................... 53 
 
 xii 
 
 Page 
Figure 17. Representative (a) bright-field phase and (b) epifluorescence micrographs 
of resealed ghosts loaded with glycylglycine-FITC conjugate. (Scale bar 
represents 5 μm.)............................................................................................... 54 
Figure 18. Change in integrated signal upon injection of resealed ghosts loaded with 
glycylglycine-FITC conjugate into rat. Injections of 500 µL and 900 µL 
result in signal increases of 0.72% and 1.03%, respectively. ........................... 55 
Figure 19. Cartoon illustrating the basic setup of the portable optical system (figure 
not drawn to scale). ........................................................................................... 61 
Figure 20. Chemical structure of NIR dye I developed for the in vivo realization of the 
dye-loaded RBC concept. pH sensitivity of the molecule is imparted by the 
methylpiperazine (indicated with green dashed line). ...................................... 64 
Figure 21. (a) Raw and (b) normalized spectra of free NIR dye I [0.41 µm] in a 2:1 
solution of NaCl:PBS show the pH sensitivity of the dye. (c) Ratio of 
intensities at 830 nm and 880 nm shows a 67.17% change in signal over the 
physiologically-relevant pH range of 6.5 to 7.3. .............................................. 64 
Figure 22. (a) Raw and (b) normalized spectra of NIR dye I display the fluorescence 
increase and the approximately 40 nm blue shift due to addition of 41.67 
µM BSA to 8.24 µM NIR dye I in PBS. (c) Normalized integrated 
intensities show an 11-fold fluorescence increase. ........................................... 66 
Figure 23. Change in NIR dye I [24.7 µM] fluorescence signal upon addition of (a) 
Hb and (b) membranes. ..................................................................................... 68 
Figure 24. (a) Raw and (b) normalized spectra of the NIR dye I:Hb complex in a 2:1 
solution of NaCl:PBS show the pH sensitivity of the dye. (c) Ratio of 
intensities at 830 nm and 880 nm shows a 21% change in signal between 
the physiologically-relevant range of pH 6.5 to 7.2, a muted response 
compared with the pH sensitivity of free NIR dye I. ........................................ 69 
Figure 25. (a) Normalized fluorescence spectra display the shift in spectrum as a 
function of ethanol concentration. (b) Greater than 100-fold increase in 
integrated fluorescence resulting from an increased ratio of ethanol to water. 71 
Figure 26. Deepening in color of NIR dye I [12.3 µM] sample is due to an increase in 
the ethanol to water ratio (i.e., samples 2 and 3 represent 0% and 50% 
ethanol). ............................................................................................................ 71 
 
 xiii 
 
 Page 
Figure 27. Increasing ethanol concentration results in a greater than 32-fold increase 
in NIR dye I [9.34 µM] fluorescence. ............................................................... 72 
Figure 28. Chemical structure of NIR dye II highlights the addition of sulfonate 
groups compared with NIR dye I to reduce dye aggregation. ........................... 73 
Figure 29. Absorbance spectrum of NIR dye II [5 µM] in PBS. ...................................... 73 
Figure 30. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 670 nm 
excitation source and bench-top spectroscopy system. Representative (a) 
raw and (b) normalized spectra as a function of pH. ........................................ 74 
Figure 31. pH sensitivity of 2.2 µM NIR dye II in PBS as measured with a 785 nm 
excitation source and bench-top spectroscopy system. (a) Raw and (b) 
normalized spectra as a function of pH. ........................................................... 75 
Figure 32. Calibration curves for (a) 670 nm excitation and (b) 785 nm excitation 
show increases in the ratio of 16.34% and 29.42% across pH 6.85 to 7.5, 
respectively. ...................................................................................................... 76 
Figure 33. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 670 nm 
excitation source and portable, fiber-based optical system. (a) Calibration 
curve shows an increase in the ratio of 14.86% across approximately pH 
6.85 to 7.5. (b) Time-course measurements of pH and ratio show that the 
two variables track each other well. ................................................................. 77 
Figure 34. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 785 nm 
excitation source and portable, fiber-based optical system. (a) Calibration 
curve shows an increase in the ratio of 31.67% across pH 6.85 to 7.5. (b) 
Time-course measurements of pH and ratio show that the two variables 
track each other well. ........................................................................................ 77 
Figure 35. The effect of pH on NIR dye II can be observed via the difference in color 
of a 20 µM NIR dye II sample at (a) high and (b) low pH levels. .................... 78 
Figure 36. pH sensitivity of NIR dye II-loaded bovine cells as measured with a 785 
nm excitation source and bench-top spectroscopy system. (a) Raw and (b) 
normalized spectra show fluorescence decrease and blue shift with 
increasing pH. (c) Calibration curve shows an increase in the ratio of 
13.24% over the physiological range of pH 6.82 to 7.51. ................................ 79 
 
 xiv 
 
 Page 
Figure 37. Bolus injections of free NIR dye II lead to rapid increases (approximately 5 
min to peak value) in measured signal followed by a slower decrease in 
signal, likely due to dye removal from the bloodstream. The data can be fit 
with a linear trendline (y = 0.6762x – 0.4801) with R2 greater than 0.99. ....... 81 
Figure 38. Voltage increase as a function of dye concentration within the blood for 
data taken across five different animals. The data can be fit with a linear 
trendline (y = 0.5749x – 0.4149) with R2 ≈ 0.95. ............................................. 82 
Figure 39. Examples of three different samples of NIR dye II-loaded ghosts obtained 
using an identical loading procedure. The differences observed among the 
samples points to problems inherent to the loading procedure. Samples 
shown in (a) and (b) contain 4 layers while the sample in (c) contains 5 
distinct layers. ................................................................................................... 83 
Figure 40. Overlay of DIC and fluorescence micrographs of (a) NIR dye II-loaded 
horse ghosts and (b) the shorter wavelength dye derivative-loaded horse 
ghosts. Use of a shorter wavelength dye allows for visualization of 
fluorescence from dye-loaded ghosts. Approximately 20% of the ghosts 
have been successfully loaded with dye. .......................................................... 85 
Figure 41. Overlay of bright-field and fluorescence micrographs of NIR dye II-loaded 
bovine ghosts show that approximately 35% of the ghosts were successfully 
loaded with dye. ................................................................................................ 85 
Figure 42. Bolus injections of NIR dye II loaded within horse RBCs using a dilution 
technique. (a) and (b) are representative of two different samples within 
different rats. ..................................................................................................... 87 
Figure 43. (a) Difference between the fluorescence spectra of a solution of free 
glycylglycine-FITC conjugate (dark green) and glycylglycine-FITC 
conjugate loaded within high Hb bovine ghosts (light green). Shaded areas 
represent the two absorption peaks of the oxygenated Hb spectrum. (b) 
Greater than 8x increase in signal upon lysing the loaded cells (light blue) 
with water, which releases the glycylglycine-FITC conjugate loaded within 
the cells. Less than 1.5x signal increase results from an equivalent dilution 
with 165 mM NaCl, which does not lyse the cells. .......................................... 90 
 
 
 
 xv 
 
 Page 
Figure 44. (a) Raw and (b) normalized fluorescence spectra of 5 µM NIR dye II as a 
function of temperature show a 20.35% increase in integrated signal with 
increased temperature from 4 °C to room temperature. (c) Raw and (d) 
normalized fluorescence spectra of 20 µM NIR dye II as a function of 
temperature show significant spectral changes and a 422.9% increase in 
integrated signal with increased temperature. Note: line colors darken with 
temperature. ...................................................................................................... 93 
Figure 45. NIR dye II samples are displayed from high to low concentration (left to 
right) at (a) 4 °C and (b) room temperature. Blue color of the high 
concentration (i.e., 5 µM and higher) samples develops as temperature 
increases. ........................................................................................................... 94 
 
 xvi 
 
LIST OF TABLES 
 Page 
Table 1. Physical dimensions (average, 𝒙, and standard deviation, σ) of ZnO samples. . 14 
Table 2. Change in signal in response to exposure to continuous excitation for 30 sec 
in different gas environments. .......................................................................... 19 
Table 3. Time constants for signal decay of free dye and dye-loaded ghosts following 
injection into a rat. ............................................................................................ 87 
Table 4. Effective concentrations of loaded ghosts within rat compared with 
maximum concentration achievable assuming free dye. .................................. 91 
 
 1 
 
1. INTRODUCTION  
 
1.1 Photoluminescence 
 Photoluminescence is broadly defined as the emission of light following 
absorption of a photon and can be further categorized based on the mechanism of action. 
1.1.1 Fluorescence and Phosphorescence 
 Fluorescence is characterized by the preservation of spin multiplicity, whereby 
the electron in an excited singlet state is paired to an electron with the opposite spin in 
the ground singlet state. Return to the ground state is therefore allowed, leading to rapid 
photon emission from the excited singlet state with rates typically on the order of 108 s-1. 
Phosphorescence, on the other hand, is characterized by emission from an excited triplet 
state following intersystem crossing from an excited singlet state. Furthermore, the 
electrons in the excited triplet and ground singlet state possess the same spin. As a result, 
transitions are considered forbidden, leading to considerably slower emission rates (103 
to 100 s-1) [1]. 
 Photoluminescence processes, including absorption and emission, are typically 
portrayed on a Jablonski diagram (named for Alexander Jablonski, the father of 
fluorescence spectroscopy). An example of a Jablonski diagram is shown in Figure 1.  
According to the Franck-Condon principle, absorption occurs instantaneously, or at least 
at a time scale too short for nuclear displacement, and is therefore represented by a 
vertical line on the diagram. The molecule is typically excited to a higher vibrational 
level within an excited state, S1 or S2, and relaxation to the lowest vibrational level 
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occurs through a process known as vibrational relaxation (within the same excited state) 
or internal conversion (relaxation to a lower excited state). Emission of a photon, then, 
occurs upon relaxation from the lowest vibrational level of the excited state – the 
thermally-equilibrated state – to the ground state. As a result, the emission spectrum of a 
fluorophore is not dependent upon the excitation wavelength, a principle known as 
Kasha’s rule. Similar to absorption, emission occurs to a higher vibrational state within 
the ground state, S0, which then rapidly relaxes to the lowest vibrational level. 
Consequently, the absorption and emission spectra of a fluorophore are typically mirror 
images of each other. A molecule in an excited singlet state can also go through 
intersystem crossing, i.e., spin conversion to the excited triplet state, T1. Emission from 
the excited triplet state, a forbidden process, is phosphorescence. Both fluorescence and 
phosphorescence emission typically occur at a longer wavelength, or lower energy, than 
absorption, which is observed as a displacement of the spectrum known as the Stokes 
shift. This shift is a result of energy loss due to vibrational relaxation in both the excited 
and ground states, as well as a number of other effects such as energy transfer and 
solvent effects [1]. 
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Figure 1. Example Jablonski diagram displaying various photoluminescence processes 
with energy on the y-axis. Bold horizontal lines represent the ground vibrational states of 
the ground (S0) and excited singlet (S1 and S2) and triplet (T1) electronic energy states. 
The thinner horizontal lines are representative of vibronic energy levels corresponding to 
each electronic energy level. Radiative and nonradiative processes are designated with 
straight and wavy lines, respectively. 
 
 
 
1.1.2 Semiconductor Luminescence 
 For direct band gap semiconductors, absorption of a photon with energy higher 
than its band gap results in the transition of an electron from the valence to conduction 
band, creating an electron-hole pair. Upon recombination of an electron and hole, a 
photon is emitted with energy similar to that of the semiconductor’s band gap energy [2]. 
Emission due radiative recombination, termed exciton emission, occurs in the UV region 
of the spectrum [3]. Defects (e.g., vacancies) within the semiconductor material can 
efficiently trap electrons and/or holes, resulting in changes in the optical properties. 
Recombination of the electron and hole results in a second emission band at a lower 
energy, or higher wavelength, than that of the exciton emission band [4].  
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1.2 Photoluminescence-Based Sensing 
 Sensing is a broad field that aims to transform information from one form to 
another, measurable form. The International Union of Pure and Applied Chemistry 
(IUPAC) provides the following definition for chemical sensing [5]: 
 “A chemical sensor is a device that transforms chemical information, 
ranging from the concentration of a specific sample component to total 
composition analysis, into an analytically useful signal.” 
They further classify chemical sensors according to the operating principle, for example, 
an optical-based sensor, which is then subdivided into the applied optical properties 
(e.g., fluorescence) [5]: 
“Optical devices transform changes of optical phenomena, which are the 
result of an interaction of the analyte with the receptor part.” 
In the presence of the analyte, the observable change in the spectral properties (e.g., 
intensity change or spectral shift) can be measured, allowing for optical-based analyte 
monitoring. Fluorescence-based sensing offers many advantages over other sensing 
methods including very high sensitivity to the analyte of interest as well as speed, which 
is typically limited by factors other than the fluorescence response. An advantage that is 
particularly useful in the biomedical field is that the propagation of light allows the 
opportunity for noninvasive, remote sensing. Fluorescence sensing can be applied to a 
wide range of analytes – gases, pH, proteins, etc. – in an endless number of 
environments – air, solution phase, living cells, etc. [6].  
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 Sensors are typically described by a number of characteristics that together 
determine how well a sensor responds to a given analyte of interest. The limit of 
detection is the lowest measurable analyte concentration and is a function of the 
measurement instrumentation and sources of noise (e.g., instrument noise, background 
fluorescence, scattering, etc.). The sensitivity is the slope of the calibration curve that 
describes the measured signal as a function of the analyte. The dynamic range describes 
the concentration range of the analyte that can be measured [6]. 
1.2.1 Wavelength-Ratiometric Measurements for Luminescence Sensing 
For some analyte-sensitive dyes, the entire fluorescence band shifts as a function 
of analyte concentration. The shift stems from a change in the electronic transitions due 
to intermolecular interactions that affect the energies of the ground and excited states. In 
the case of a dye displaying this property, the result is an increase in intensity at one 
edge of the band with a concomitant decrease in the other edge. A two-channel 
ratiometric measurement of the intensity levels at these two points may serve as a 
method for monitoring analyte levels. There are a number of advantages to ratiometric 
sensing over traditional intensity-based sensing. First, the ratio would be dependent upon 
analyte concentration only, rather than on the concentration of the analyte-sensitive dye. 
Furthermore, photobleaching should affect the entire emission spectrum, thereby leaving 
the ratio unchanged and able to reliably relay the analyte concentration [6]. 
1.3 Unintended Sensitivity of Fluorophores to their Environment 
 Analyte-sensitive fluorescent dyes may also be sensitive to other, unintended 
aspects of their environment, such as the temperature (thermal quenching) or polarity of 
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the solvent (solvatochromism). Static quenching decreases with increased temperature 
due to disruption of the complexes responsible for quenching; conversely, dynamic 
quenching increases with increased temperature due to increased rate of diffusion of the 
quencher [6]. Dyes may exhibit either bathochromic (red) or hypsochromic (blue) shifts 
with increasing solvent polarity. Solvatochromism is attributed to a differential solvation 
between the ground and first excited states. If the molecule in the ground state is better 
stabilized by solvation as polarity increases than in the excited state, then the molecule 
will undergo negative solvatochromism (i.e., hypsochromic shift). Conversely, if the 
molecule is better stabilized in the excited state, it will undergo positive 
solvatochromism (i.e., bathochromic shift). In addition to shifts in the spectra of 
solvatochromic dyes, solvent polarity can affect the intensity of the bands [7, 8]. Some 
dyes are known to show sensitivity to proteins, as shown by a substantial increase in 
fluorescence and spectral shift upon addition of protein. This signal increase is thought 
to result from the dye binding within a hydrophobic pocket of the protein [1]. 
1.4 Outline of Dissertation 
The photobleaching studies of various zinc oxide (ZnO) structures as well as the 
application of ZnO nanoparticles to monitoring of humidity levels in air and nitrogen are 
discussed in Section 2. Sections 3 and 4 are devoted to the development of a red blood 
cell (RBC)-based sensing platform. Specifically, monitoring of extracellular pH levels 
via changes in fluorescence of an intracellular glycylglycine-fluorescein isothiocyanate 
(FITC) conjugate is discussed in Section 3. Section 4 focuses on the development of a 
near-infrared (NIR) sensing system towards the application of these sensors for in vivo 
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monitoring. Finally, Section 5 provides conclusions on the present work and an outlook 
on future work that would build upon the results presented here. 
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2. APPLICATION OF ZINC OXIDE NANO- AND MICROSTRUCTURES TO 
OPTICAL HUMIDITY SENSING 
 
2.1 Background 
2.1.1 Zinc Oxide 
 ZnO is a II-VI semiconductor possessing a number of valuable properties such as 
a direct band gap of 3.37 eV at room temperature and a large exciton-binding energy of 
60 meV that leads to photoluminescence at room temperature; simple and inexpensive 
production of nano/microstructures that lends itself to incorporation into low-cost 
devices; and biocompatibility that is relevant for biomedical applications [9, 10]. 
Combined, these characteristics make ZnO a promising material for various sensing 
schemes.  
2.1.2 Electrical-Based Sensing with ZnO 
 Traditionally, sensing with metal oxides has been performed by measuring 
changes in electrical conductivity, resulting from an interaction between an adsorbed 
molecule and the metal oxide surface. ZnO has been used to monitor changes in a 
number of gases, including nitrogen dioxide (NO2) [11-17], ethanol [12, 18-21], ozone 
[22, 23], acetone [12], and carbon monoxide (CO) [11, 24, 25], as well as for monitoring 
changes in the local humidity level [26]. Although there have been many promising 
results, conductometric-type sensors still suffer a number of disadvantages, including the 
requirement for electrode contacts and the need for elevated working temperatures in 
nearly all cases. Thus, the advantages of an optical-based scheme, such as the ability for 
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remote, contactless sensing at room temperature, have led to investigation into 
environmental sensing based on changes in ZnO luminescence.  
2.1.3 ZnO Luminescence and Optical-Based Sensing 
When excited in the UV, ZnO exhibits two emission bands, one in the UV – 
near-band edge emission stemming from excitonic emission – and a second, much 
broader peak in the visible region – stemming from deep-level defects within the crystal 
structure [9, 10]. Although the exact mechanism behind the visible emission is still under 
investigation, oxygen vacancies are commonly cited defects [3, 27-30]. Luminescence 
emission, similar to the conductivity, is sensitive to changes in the local environment of 
the sample. Optical-based sensing techniques have been used to study primarily NO2 
[22, 31-37], ethanol [34, 37, 38], and humidity [34, 37, 39, 40].  
 A more detailed discussion of the studies involving humidity is appropriate given 
the scope of the work presented here. Using a vapor transport technique, Baratto et al. 
prepared ZnO nanowires with widths of 300 nm and lengths of several microns and 
applied this material to NO2, ethanol, and humidity sensing [37]. A quenching of 2.3% 
of the luminescence was observed upon exposure to 0.1 ppm NO2 and increased to an 
8% quenching in 2 ppm NO2. Luminescence enhancements of 2.8%, 3.9%, and 4.6% 
were observed in response to 20%, 50%, and 70% relative humidity (RH) while 
enhancement of 1.5% was observed for 1000 ppm ethanol. Comini et al. prepared ZnO 
nanowires with widths ranging from 72 to 78 nm and lengths spanning several microns 
using a vapor transport process [34]. The nanowires exhibited a reduction in 
luminescence of 27% when exposed to 16 ppm NO2. The authors also investigated the 
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effects of ethanol and humidity on the signal, observing a 4% signal reduction in 
response to 30% humidity and a 7% signal increase due to 900 ppm ethanol. Aneesh et 
al. employed evanescent wave absorption spectroscopy to monitor humidity levels using 
a decladded optical fiber that had been uniformly coated with a ZnO nanoparticle-doped 
film [39]. Utilizing changes in optical intensity due to absorption of the film at 632.8 
nm, the sensor exhibited a linear response across a range of 4% and 96% RH with a 
sensitivity of 0.0012 RH-1. Liu et al. grew ZnO nanorods with diameters ranging from 
200–300 nm and a maximum length of 2.5 µm on the surface of a thinned silica fiber 
[40]. Optical transmission at 644 nm decreased as humidity increased over the range of 
10-95% RH with a maximum sensitivity of 0.014 RH-1 using a nanorod-coated, 5 µm 
diameter optical fiber. The authors indicated that the increased sensitivity compared with 
larger diameter optical fibers is likely due to an increased proportion of light interacting 
with the external medium (e.g., humidity). For luminescence-based humidity sensing, 
the mechanism employed in this paper, larger nanostructures have generally been the 
focus of the literature, but there has not been a consensus regarding humidity effects on 
luminescence. As a result, the effects of ZnO structure size on optical sensing properties 
are not well understood. Thus, there is a need to investigate optical properties across 
multiple size regimes to determine which ZnO structure possesses the best qualities, 
specifically sensitivity and range, for environmental sensing. 
2.1.4 Clinical Relevance of ZnO for Monitoring NO2 and CO 
 The proof-of-concept work presented here for ZnO nanoparticle-based monitors 
for local humidity levels can be extended to other environmental gases. Of particular 
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relevance is the application of ZnO towards NO2 and CO monitoring. The World Health 
Organization has identified indoor and outdoor air pollution as a major health problem 
for both developed and developing countries. However, the greatest burden falls on 
those people living in low- and middle-income countries. NO2, which results from 
combustion processes (e.g., heating, engines, etc.), is a known contributor to outdoor air 
pollution. Epidemiological studies have revealed a correlation between long-term NO2 
exposure and symptoms of bronchitis in asthmatic children as well as reduced lung 
function growth [41]. CO, which results from inefficient burning of organic fuel, is the 
leading cause of poisoning in the United States [42]. In developing countries in 
particular, CO is a major concern as it is released upon burning wood or charcoal, 
common fuel sources supplying between 50% and 95% of domestic energy needs. Poor 
ventilation and low combustion efficiency increase the harmful health effects in these 
countries [43]. CO irreversibly binds to hemoglobin (Hb), which blocks the binding and 
transport of oxygen and can lead to death [42]. Thus, proper monitoring and control of 
NO2 and CO levels, in particular with a sensing system based on ZnO owing to its low 
cost, are important for global health. 
2.2 Materials and Methods 
2.2.1 Sample Preparation 
 ZnO nanoparticles were prepared using a method originally reported by Haase et 
al. [44].  Briefly, hydrolysis was initialized by addition of 65 mL of 30 mM NaOH to 
125 mL of 10 mM zinc acetate solution (Zn(CH3COO)2 ∙ 2H2O, >98%, Sigma-Aldrich) 
in methanol with rapid stirring. The mixture was refluxed for two hours at 60 °C on a hot 
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plate. The prepared ZnO nanoparticles were used as seed material for subsequent 
generation of nanopods, which was accomplished by mixing 100 µL of ZnO 
nanoparticles (2.9 µM) with 2 mL of a growth solution consisting of an equimolar 
mixture of zinc nitrate hexahydrate (Zn(NO3)2·6H2O, 99%, Sigma-Aldrich) and 
hexamethylenetetramine (HMT, C6H12N4, 99%, Sigma-Aldrich) at 25 mM [45]. This 
mixture was then heated to 170 °C under 100-150 psi of pressure in a single-mode 
microwave (Discover® system, CEM). After being held at 170 °C for 20 min, 
compressed air was flowed into the microwave to cool the reaction mixture. Microrods 
were prepared by placing a 2 mL volume of an equimolar ratio of Zn(NO3)2 and HMT at 
25 mM in a glass vessel within the single-mode microwave, as described previously 
[46]. Similar to the nanopods, the solution was heated to 170 °C and held for 20 min, 
followed by rapid cooling by flow of compressed air. All ZnO samples were cleaned 
with methanol and subsequently stored in methanol at 4 °C until application. For optical 
experiments, a small volume of ZnO solution was placed inside of a 1 cm path length 
quartz cuvette and placed under a steady stream of nitrogen to evaporate the methanol, 
leaving a film of ZnO nano/microstructures. 
2.2.2 Optical System 
 A custom optical system was used to collect all ZnO luminescence data. A mode-
locked Ti:sapphire laser (Mira 900, Coherent) at 700 nm was frequency doubled via a 
Type 1 BBO crystal prior to the sample stage to produce 350 nm excitation. 
Luminescence was collected at 90° with a CCD-coupled spectrometer (Acton SpectraPro 
2300i, Princeton Instruments). Residual 700 nm laser line and 350 nm excitation were 
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removed by a short-pass filter (650 nm cut-off, OD 4, Edmund Optics) and long-pass 
filter (395 nm cut-off, Edmund Optics), respectively. For time-course measurements, the 
signal was integrated from 450 nm to 690 nm – the visible, defect-related band. Periodic 
excitation schemes were accomplished by employing a software-controlled, mechanical 
shutter (SH05, Thorlabs) in the beam path. Humidity levels were prepared by mixing dry 
and wet gas at predetermined flow rates for the desired humidity. Humidity 
measurements were performed with a modified commercial humidity monitor (20-90% 
RH range; 1% RH resolution; VWR). Sensitivity (% signal change / % RH) was defined 
as the slope of the regression line of the calibration curve for luminescence as a function 
of RH. For comparison with other methodologies, normalized sensitivity (RH-1) was 
defined as the slope of the calibration curve normalized to the highest luminescence 
value. 
2.3 Results and Discussion 
2.3.1 ZnO Characterization 
 The optical characteristics of three ZnO nano/microstructures, with widely 
varying surface area to volume ratios, were investigated via luminescence spectroscopy. 
The ZnO structures analyzed in this work consisted of (1) ZnO nanopods – multiple-
legged structures; (2) ZnO microrods – single hexagonal structures; and (3) ZnO 
nanoparticles. The physical dimensions of the ZnO nanoparticles were characterized 
using transmission electron microscopy (TEM) and corroborated with an effective mass 
model based on the onset of UV-visible absorption. Scanning emission microscopy 
(SEM) and TEM, coupled with an x-ray diffractogram, were used for characterization of 
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nanopods [45]. Similarly, the dimensions of the ZnO microrods were characterized using 
SEM [46]. The physical dimensions of these samples are summarized in Table 1. The 
samples were excited at 350 nm (1 mW, 75 mm focal length lens), and emission from 
the various samples was collected at 90° with a CCD-coupled spectrometer. Sample 
luminescence spectra of ZnO nanoparticles (dark blue) and microrods (light blue) are 
shown in Figure 2; the 450-690 nm band integrated for time-course measurements 
reflects the defect-related luminescence from the samples. 
 
 
 
Table 1. Physical dimensions (average, ?̅?, and standard deviation, σ) of ZnO samples. 
 
Sample Length, ?̅? (nm) Length, σ (nm) Dia., ?̅? (nm) Dia., σ (nm) 
Nanoparticles - - 4.1 0.8 
Nanopods 275 25 15.44 1.89 
Microrods 1450 100 380 60 
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Figure 2. Luminescence spectra of ZnO nanoparticles (dark blue) and microrods (light 
blue). Time-course luminescence data were integrated from 450 nm to 690 nm, the 
defect-related band. 
 
 
 
2.3.2 Photobleaching Studies 
 Upon excitation, all ZnO nano/microstructures exhibited reversible 
photobleaching that recovered over time in the absence of excitation. The rate and extent 
of recovery depended on exposure dynamics (e.g., exposure and recovery times). As 
shown in Figure 3, ZnO nanoparticles exposed to a 1 sec excitation every 10 sec 
exhibited signal recovery following a 20 min period of recovery time. After 5.5 min of 
excitation, the signal dropped to 31.4% of the original signal but recovered to 75.61% of 
the original signal following a 20 min recovery period. Following a second excitation 
period, the signal dropped to 28.22% of the original signal, recovering to 73.18% 
following a second 20 min recovery period. 
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Figure 3. Recovery of ZnO nanoparticle luminescence following 20 min recovery 
period (blocked excitation). 
 
 
 
 To further explore the reversible photobleaching phenomenon, the 
photobleaching rates of the three samples were analyzed using various excitation 
schemes (i.e., continuous or periodic excitation) under constant flow of dry nitrogen. 
Following 30 sec of continuous excitation (350 nm, 1 mW, 75 mm focal length lens, 1 
sec integration), nanoparticles, nanopods, and microrods exhibited 60.99% ± 8.88% 
(n=24), 22.82% ± 5.76% (n=20), and 8.99% ± 2.34% (n=23) photobleaching, 
respectively (Figure 4a). For the nanoparticle sample in particular, high variability 
between measurements may preclude the use of these materials for optical sensing. By 
modifying the excitation scheme, however, it was possible to reduce the variability 
among photobleaching measurements. 
 Employing periodic excitation – 1 sec exposure followed by a specified recovery 
period without excitation, ranging from 5 to 20 sec – reduced the standard deviation 
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observed among measurements following 30 exposures for most cases. Furthermore, 
increasing the recovery time to 10 or 20 sec contributed to a statistically significant 
(p<0.01) reduction in measured photobleaching compared with the 5 sec scheme for the 
nanoparticle sample. However, increasing the recovery time from 10 to 20 sec did not 
yield further benefits in photobleaching or variability. With an exposure time of 1 sec 
and recovery times of 5, 10, and 20 sec, the nanoparticles exhibited 64.74% ± 2.58% 
(n=5), 55.57% ± 3.94% (n=5), and 53.30% ± 3.97% (n=5) photobleaching, respectively, 
after 30 exposures (i.e., 30 sec total excitation). For the same periodic excitation 
schemes, the nanopods experienced 22.40% ± 3.53% (n=4), 27.34 ± 2.81% (n=3), and 
27.38% ± 2.52% (n=4) photobleaching after 30 exposures. Likewise, the microrods 
experienced 12.52% ± 4.18% (n=3), 13.01% ± 2.81% (n=3), and 10.33% ± 2.83% (n=3) 
photobleaching after 30 exposures. These results are displayed graphically in Figure 4b. 
 
 
 
 
Figure 4. (a) Percent photobleaching of ZnO samples following 30 sec of continuous 
excitation (1 mW, 350 nm). (b) Percent photobleaching of ZnO samples after 30 
exposures of periodic excitation. Each 1 sec excitation is followed by either 5, 10, or 20 
sec of recovery time during which the laser beam is blocked. 
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 Using the size dimensions summarized in Table 1, the surface area to volume 
ratios of the three ZnO nano/microstructures were calculated and compared with their 
associated photobleaching characteristics. The percentage of photobleaching increased 
with increasing surface area to volume ratio for both continuous (Figure 5a) and periodic 
(Figure 5b) photobleaching schemes, indicating an increasing reactivity with surface 
area to volume ratio. This reactivity is related to surface states, which have a higher 
contribution to the luminescence emission in smaller structures possessing higher 
surface area to volume ratios. These results agree with findings in the literature. Ghosh 
et al. showed that the sensitivity of the sample to the environment is size-dependent, 
with sensitivity increasing as particle size decreases [47]. Similarly, Eriksson et al. 
showed that ZnO nanoparticles have higher sensitivity than films, owing to the higher 
surface area to volume ratio [48].  
 
 
 
 
Figure 5. Percent of photobleaching following 30 sec of total excitation as a function of 
surface area to volume ratio due to 1 mW of (a) continuous excitation at 350 nm and (b) 
periodic excitation at 350 nm using exposure schemes of 1 sec excitation followed by 
recovery times of 5, 10 or 20 sec. 
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2.3.3 Environmental Effects on ZnO Luminescence 
 Prior to applying the samples as humidity sensors, the effect of the type of carrier 
gas on luminescence was first analyzed. The signal change for each ZnO sample in dry 
nitrogen was previously determined during the continuous photobleaching experiments. 
As such, the sample chamber was equilibrated to a dry air environment, and the change 
in signal for each ZnO sample was observed. The data for both carrier gases are 
summarized in Table 2. For both microrods and nanopods, continuous photoexcitation 
caused a decrease in the signal level for both environments. However, the nanoparticles 
exhibited a drastic difference between the two carrier gas environments, as the 
luminescence increased upon exposure to light in a dry air environment. This finding is 
indicative of an interaction between gas components within air (i.e., other than nitrogen) 
and ZnO nanoparticles in the presence of continuous excitation. Furthermore, this is 
consistent with findings by Ghosh et al. that introduction of oxygen into an evacuated 
chamber with ZnO nanoparticles results in an increase in luminescence over ZnO 
nanoparticles in air [47]. 
 
 
 
Table 2. Change in signal in response to exposure to continuous excitation for 30 sec in 
different gas environments. 
 
Dry Air Dry Nitrogen 
Nanoparticles +32.68% -60.99% 
Nanopods -18.60% -22.82% 
Microrods -9.84% -8.99% 
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 The reactivity of the nanoparticle sample was further investigated by adjusting 
the excitation scheme during data collection under a constant flow of dry nitrogen 
(Figure 6a). Similar with the results in Table 2, the signal initially decreased upon 
exposure to UV excitation in a dry nitrogen environment. Periodic blocking of the 
excitation beam resulted in an increase in signal for the nitrogen environment, where 
each decrease in the length of recovery time resulted in increasingly smaller changes in 
signal when switching between continuous and periodic excitation. For example, the 
absolute differences between maximum quenching during continuous excitation and 
maximum signal recovery during 1 sec excitation followed by either 20, 10, or 5 sec 
recovery periods (calculated on either side of the recovery period) were 31.80 ± 3.24%, 
22.47 ± 0.06%, and 15.14 ± 0.06%, respectively. In contrast, nanoparticles in a dry air 
environment exhibited the opposite reaction when changing between continuous and 
periodic excitation schemes. Consistent with the results of Table 2, nanoparticles 
exhibited an increase in signal upon exposure to continuous excitation in a dry air 
environment, as shown in Figure 6b. However, when exposed to periodic excitation, 
luminescence decreased following a biexponential curve. This pattern continued upon 
cycling between continuous and periodic excitation schemes. 
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Figure 6. Luminescence response to changes in excitation scheme in (a) dry nitrogen 
and (b) dry air. Grey areas represent segments of time during which the sample received 
continuous excitation. As indicated, the other regions are time periods of periodic 
excitation (left: 1 sec excitation followed by 20 sec recovery time, middle: 1 sec 
excitation followed by 10 sec recovery time, and right: 1 sec excitation followed by 5 
sec recovery time). 
 
 
 
 Comparison of the photobleaching results among the three size regimes coupled 
with the environmental results indicates that the nano/microstructure surface is key to 
the interesting optical properties observed with ZnO. It is hypothesized that the ZnO 
nanoparticles, with heightened reactivity to photoexcitation and changes in environment, 
have the greatest potential for serving as environmental sensors with high sensitivity. 
2.3.4 Humidity Sensing 
As shown above, ZnO nanoparticles exhibit sensitivity to their environment, as 
demonstrated by their reaction to various excitation schemes in the presence or absence 
of oxygen. This is further verified in Figure 7, which demonstrates the effect of dry 
nitrogen, humid nitrogen, and ambient air exposure on ZnO nanoparticle luminescence. 
Following signal stabilization in dry nitrogen, ZnO luminescence increased upon 
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exposure to ambient air, presumably due to the increased percentage of oxygen present. 
Conversely, introduction of humid nitrogen has the effect of decreasing luminescence 
below the level of dry nitrogen. 
 
 
 
 
Figure 7. Luminescence of ZnO nanoparticles in different environments: (1) dry 
nitrogen; (2) ambient air; (3) humid nitrogen; (4) dry nitrogen; (5) ambient air; and (6) 
dry nitrogen. Ambient air, likely due to the presence of oxygen, results in an increase in 
luminescence. 
 
 
 
 To rule out effects of interferents that may cause an undesired signal change, a 
single carrier gas was used for humidity sensing experiments (i.e., nitrogen or air). To 
control the humidity level in the sample chamber, flow rates of dry gas and humid gas 
exiting a custom-built humidifier were varied at pre-determined values to obtain the 
desired humidity level over the range of the humidity analyzer (i.e., 20-90% RH). Prior 
to photoexcitation for each humidity level tested, the sample chamber was equilibrated 
with dry gas. The sample was then photobleached until the signal reached and 
1 2 3 4 5 6 
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maintained a steady-state level; thus, changes in signal would not be due to 
photobleaching of the sample. 
 Using results from the photobleaching experiments, the optimal excitation 
scheme to employ for humidity sensing experiments was determined to be periodic 
excitation with a 1 sec excitation followed by a recovery time of 10 sec. This periodic 
timing scheme results in variability among measurements similar to or better than 
continuous excitation. For nanoparticles – the focus of the humidity sensing presented in 
this paper – 1 sec excitation with a 10 sec recovery period results in a statistically 
significant reduction in photobleaching compared with 1 sec excitation with 5 sec 
recovery; further reductions in measured photobleaching or standard deviation are not 
realized when moving to a longer recovery period of 20 sec. 
 2.3.4.1 Humidity sensing with nanopods and microrods: Preliminary work 
highlighted the humidity sensing capabilities of ZnO nanopods as a proof of concept for 
using ZnO nanostructures as optical environmental sensors [45]. The nanopods 
displayed a sensitivity to humidity of 0.0032 RH-1 across a linear range of 22–70% RH.  
 Upon changing the environment from dry nitrogen to humid nitrogen, the ZnO 
microrods exhibited a 10.69 ± 2.74% decrease in signal, regardless of the humidity level 
between 31% and 90% RH. Representative curves displaying the humidity response of 
ZnO microrods in 41% and 71% humidity are shown in Figure 8a and b, respectively. 
Thus, rather than displaying a trend with humidity, the rods display an on-off signal 
change when exposed to humidity, making them poor candidates for humidity sensing. 
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Figure 8. Representative response of ZnO microrods to changes between 0% RH and 
humidity levels of (a) 41% and (b) 71% RH in nitrogen. 
 
 
 
 2.3.4.2 Humidity sensing with nanoparticles in nitrogen: In a nitrogen 
environment, ZnO nanoparticles exhibited a large decrease in luminescence in response 
to an increase in local humidity. A typical humidity curve is shown in Figure 9a. 
Following a 10 min purge with dry nitrogen, a mixture of dry and humid nitrogen at the 
desired humidity level was introduced into the system, causing a momentary increase 
and subsequent decrease in signal intensity below the dry nitrogen level. Upon return to 
dry nitrogen, the signal recovered to its initial level prior to humidity exposure. A 
calibration curve for humidity sensing was developed using % change= 
Idry-Ihumid
Idry
×100, 
where Idry is the average signal in a dry gas environment prior to humidity exposure and 
Ihumid is the average signal at the end of the humidity exposure. As shown in Figure 9b, 
the % change in luminescence increased with humidity, following a linear trend with 
R2≈0.98. It should be noted that, for all humidity levels other than 24% RH, the 
luminescence recovered to within 5% of the original dry nitrogen signal level within 
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approximately 30 min. The nanoparticles displayed a measurement range from 
approximately 23% to greater than 90% (i.e., the maximum range of the humidity 
sensor) with a sensitivity of 0.65% change in optical signal per % RH or a normalized 
sensitivity of 0.008417 RH-1. By cycling between 0% RH nitrogen and 90% RH 
nitrogen, the reversibility of the ZnO nanoparticle sensor was shown (Figure 10).  
 
 
 
 
Figure 9. (a) Typical luminescence response of ZnO nanoparticles in response to a 10 
min dry nitrogen purge followed by a 20 min exposure to nitrogen with an increased 
humidity level and a 30 min purge with dry nitrogen. (b) Optical response of ZnO 
nanoparticles to various % RH levels. The curve follows a linear trend, with % change in 
optical signal increasing with increasing % RH. 
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Figure 10. Reversibility of the ZnO nanoparticle sensor was demonstrated by cycling 
between 0% RH nitrogen and greater than 90% RH nitrogen (grey regions). 
 
 
 
 2.3.4.3 Humidity sensing with nanoparticles in air: Upon changing the carrier 
gas from nitrogen to air, the ZnO nanoparticles displayed more rapid, yet muted 
responses to changes in local humidity. Figure 11a displays sample response curves of 
ZnO nanoparticles to 54% (dark blue) and 66% (light blue) humidity in air. The muted 
response is likely a result of competing reactions between air and humidity. As shown in 
Table 2, ZnO nanoparticles exhibited an increase in luminescence upon excitation in air, 
while the opposite was seen in a nitrogen environment. Given that humidity has the 
effect of reducing luminescence, it follows that a reduced effect of humidity would be 
observed in an air environment. 
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Figure 11. (a) Response of ZnO nanoparticles to changes from 0% RH to 54% RH (dark 
blue) and 66% RH (light blue) in air. (b) Response of ZnO nanoparticles to changes in 
humidity within an air environment. 
 
 
 
 As shown in Figure 11b, the % change in luminescence increased with humidity, 
following a linear trend with R2>0.95. Although the percent signal change is less in an 
air environment, the nanoparticles exhibited increased sensitivity in the range of 40–90% 
RH compared with the response in nitrogen. The nanoparticles displayed a measurement 
range from 43% to greater than 90% with a sensitivity of 0.75% change in signal per 
%RH or a normalized sensitivity of 0.01898 RH-1. Below 43% RH, our system could not 
discern changes in signal in response to changes in humidity. 
 The normalized sensitivity for ZnO nanoparticles to changes in humidity in 
nitrogen and air are 0.008417 RH-1 and 0.01898 RH
-1, respectively. In air, the ZnO 
nanoparticles presented in this paper show an increased sensitivity to humidity when 
compared with published normalized sensitivity values of (1) 0.00784 RH-1 for 
luminescence-based sensing with nanowires having widths of 300 nm [37], (2) 0.014 
RH-1 for optical transmission-based sensing with a ZnO nanorod-coated optical fiber 
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[40], and 0.0012 RH-1 for optical transmission-based sensing using an optical fiber 
coated with a nanoparticle-doped film [39]. 
2.4 Conclusions 
 The photobleaching dynamics of three ZnO nano/microstructures were 
investigated using continuous and periodic UV excitation. Based on these findings, a 
periodic excitation scheme was employed for optical humidity sensing with 4 nm ZnO 
nanoparticles. The defect-related photoluminescence band was integrated from 450 nm 
to 690 nm and analyzed in response to variations in the local humidity level. The 
nanoparticles displayed a linear response with sensitivities of 0.65% change in signal per 
% RH (normalized sensitivity of 0.008417 RH-1) and 0.75% change in signal per % RH 
(normalized sensitivity of 0.01898 RH-1) in nitrogen and air, respectively. Given these 
results, this platform technology has great potential to be applied to other environmental 
gases. 
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3. ENCAPSULATION OF FITC TO MONITOR EXTRACELLULAR PH: A STEP 
TOWARDS THE DEVELOPMENT OF RED BLOOD CELLS AS CIRCULATING 
BLOOD ANALYTE BIOSENSORS*
 
3.1 Background 
 Analysis of various blood parameters provides insight into critical aspects of a 
patient’s physiological or biochemical state, thus providing information about organ 
function and disease status. Examples of important blood parameters include pH, 
catecholamines, and glucose, which at elevated levels is linked to diabetes [49].  
3.1.1 Clinical Relevance of Blood pH 
Blood pH is tightly regulated in the body between pH 7.35 and 7.45, the narrow 
range over which cellular metabolism and organ function are optimized. Carbonic acid 
and bicarbonate serve as the buffer pair in blood that is primarily responsible for 
maintaining the narrow physiological pH range. The pathophysiologic disturbances, 
either metabolic or respiratory, that increase or decrease hydrogen ion concentration 
(H+), measured as pH and responsible for the acid-base level of the blood, are termed 
acidosis (i.e., increase H+ ion concentration/decrease pH) and alkalosis (i.e., decrease H+ 
ion concentration/increase pH). Compensatory mechanisms (e.g., hyper/hypoventilation) 
typically respond to changes in blood pH to return the pH to normal before acidosis or 
                                                 
* Parts of this chapter are reprinted with permission from “Encapsulation of FITC to monitor extracellular 
pH: a step towards the development of red blood cells as circulating blood analyte biosensors” by S. C. 
Ritter, M. A. Milanick, and K. E. Meissner, 2011. Biomedical Optics Express, 2(7), 2012-2021, Copyright 
2011 by OSA. The paper can be found at the following URL on the OSA website: 
http://dx.doi.org/10.1364/BOE.2.002012. Systematic or multiple reproduction or distribution to multiple 
locations via electronic or other means is prohibited and is subject to penalties under law. 
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alkalosis progresses to the more severe states of acidemia (pH less than 7.35) or 
alkalemia (pH greater than 7.45). If blood pH reaches levels outside of the pH range of 
7.2–7.6, rapid intervention must take place to avoid adverse effects on the cardiovascular 
and central nervous systems [50].  
Changes in blood pH accompany a variety of diseases, such as congenital lactic 
acidosis and diabetic ketoacidosis (DKA) [51, 52]. DKA is a life-threatening 
complication of diabetes resulting from the ineffective use or lack of insulin that leads to 
an increase in counter-regulatory hormones. The disease is characterized by 
hyperglycemia, acidosis, and increased levels of ketones [53, 54]. As such, treating 
patients with DKA requires management of multiple blood analytes, including blood 
glucose and the acid-base status (i.e., pH), to ensure successful outcomes. Currently, the 
gold standard measurement for blood pH is sampling of arterial blood, which is both 
inconvenient and difficult, especially with infants and pediatric patients. A secondary 
method for estimating blood pH is measurement of transcutaneous pCO2 or end tidal 
CO2 levels [51, 55-57]. Although hourly samples are valuable, patients may experience 
rapid changes in blood pH and require immediate treatment. Thus, a long-term, 
continuous solution (e.g., a biosensor) is requisite for more complicated and serious 
conditions. 
3.1.2 Diabetes and Clinical Relevance of Blood Glucose 
 Diabetes mellitus is a set of metabolic disorders accompanied by hyperglycemia. 
These disorders may lead to a host of complications, including cardiovascular disease, 
retinopathy, nephropathy, and peripheral neuropathy. Diabetes was ranked as the 7th 
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leading cause of death in 2010 [58]. Type 2 diabetes is responsible for 90% of diabetic 
cases and is characterized by dysfunctional β-cells and insulin resistance. Although 
insulin resistance is compensated for by increased blood insulin levels at early stages of 
the disease, insulin production decreases over time, leading to hyperglycemia. Type 2 
diabetes is becoming more common in all countries, regardless of development, and 
among younger individuals [59].  
 The International Diabetes Federation estimates that 382 million people 
worldwide (or 8.3% of the population aged 20-79) were living with diabetes in 2013; 
that number is expected to rise to 592 million (or over 10% of the population) by 2035. 
The prevalence of diabetes is highest among individuals living in low- and middle-
income countries, which accounts for 80% of the total cases of diabetes but only 20% of 
total healthcare expenditures [60]. The effect of diabetes in the United States is of 
particular importance due to the increasing prevalence observed over the last few 
decades, which is expected to continue. Between 1980 and 2006, the percentage of the 
U.S. population with diabetes increased from 2.5% to 5.8%. Looking forward, models 
indicate that 1 out of every 3 children born in the U.S. in 2000 will develop diabetes in 
his or her lifetime [61]. The burden of diabetes and its complications – in terms of 
monetary expenditures, quality of life, etc. – is vast and highlights the need for a 
successful prevention and management strategy for diabetes. Thus, a glucose monitoring 
system that provides long-term, near-continuous or on-demand blood glucose 
measurements is greatly needed. 
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 3.1.2.1 Electrochemical glucose monitoring: Due to the physiological importance 
and broad-reaching benefits of proper glucose control for individuals with diabetes (e.g., 
delay or prevention of diabetes-related complications), glucose monitoring devices have 
been the subject of fervent research for over four decades [62-64]. The first enzyme-
based sensor for blood glucose measurements was developed by Clark and Lyons in 
1962 [65]; since that time, research into the development of reliable glucose biosensors 
has grown, now accounting for 85% of the biosensor market [66]. Traditionally, blood 
glucose measurements have been based on an electrochemical reaction between an 
enzyme, primarily glucose oxidase, and glucose within the blood sample, which has 
been retrieved via a finger-prick.  
 The development of glucose biosensors over the last several decades has been 
reviewed in depth in a number of reports [66-69]. Initial enzymatic biosensors detected 
glucose via a glucose oxidase-catalyzed reaction between glucose and oxygen that 
produced hydrogen peroxide and gluconic acid . Measurement of the increase in 
hydrogen peroxide or decrease in oxygen enabled quantification of glucose 
concentration [70]. One disadvantage of first generation biosensors was a dependence on 
oxygen concentration. A number of mechanisms have been developed to alleviate the 
associated errors, including the implementation of films to control transport of glucose 
and oxygen. Second generation biosensors implemented a nonphysiological electron 
acceptor (i.e., mediator) that reacted rapidly with the reduced enzyme and mitigated the 
issue of oxygen dependence. Third generation biosensors aim to eliminate the mediator 
altogether, relying on direct electron transfer between enzyme and electrode [66-68]. 
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Although enzyme implementation within these biosensors affords high sensitivity and 
selectivity for glucose, the sensors suffer from inadequate long-term stability as a result 
of the nature of the enzyme [68, 69, 71]. 
 Nonenzymatic glucose sensors, which function through the direct 
electrochemical oxidation of glucose, aim to address the major pitfall of enzymatic 
glucose biosensors – long-term stability. Glucose oxidase suffers from thermal and 
chemical instability, and reproducibility among sensor batches is limited by the 
requirement for immobilization of the enzyme. Aside from reproducibility, an enzyme-
less biosensor would afford a number of other important advantages, namely stability, 
simplicity, and freedom from oxygen effects. Despite these advantages, major issues 
facing the realization of nonenzymatic biosensors include insufficient sensitivity and 
selectivity as well as the irreversible adsorption of chloride ions and oxidation 
intermediates that hinders the electrode activity [67-70]. 
 3.1.2.2 Continuous glucose monitoring: Standard finger-prick style glucose 
meters suffer from the disadvantage of providing mere snapshots of the glucose 
concentration over time, rather than a continuous trend of glucose changes throughout 
the day. Furthermore, the invasiveness of this technique serves as an obstacle to proper 
control of blood glucose levels through self-monitoring [49, 72]. Continuous glucose 
monitoring (CGM) would provide for stricter control over blood glucose levels leading 
to improved patient outcomes. This type of system would also provide insight into rapid 
glucose fluctuations and allow for the proper therapeutic response to be administered 
[66].  
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 Recent studies have evaluated the efficacy of CGM systems with respect to 
various patient outcomes. Gandhi et al. conducted a meta-analysis of 19 trials. CGM 
resulted in a reduction in mean HbA1c in patients with Type 1 and Type 2 diabetes. 
Although trial participants generally felt favorably towards the CGM systems, some 
users felt the systems were inconvenient and led to difficulties with sleeping and athletic 
activities [73]. Similarly, other studies have shown superior glucose control with CGM 
systems [74, 75]. 
 Upon insertion in the body, CGM systems face a number of significant 
challenges to long-term implementation, towards which much research has been 
dedicated. Commercial CGM systems employ proprietary membranes to induce 
selectivity to glucose as well as reduce effects caused by fluctuations in oxygen 
concentration. To create an environment that favors reaction between the enzyme, 
glucose, and oxygen (i.e., 1:1 stoichiometric reaction between oxygen and glucose), 
membranes are employed to reduce diffusion of glucose to create an excess of oxygen, 
as glucose is naturally present at a significantly higher concentration than oxygen. 
Calibration with the standard finger-prick test is required as the in vivo response of these 
sensors differs considerably from the in vitro response. As a time lag of 5 to 30 min 
exists between the levels of glucose in the blood and interstitial fluid, where the CGM 
system is placed, careful attention must be given to the time of calibration [76]. 
 The most significant challenge for an implanted CGM system is the foreign body 
response, with an initial acute phase characterized by a decrease in sensitivity and 
stability as the body attempts to eliminate the foreign body and heal the wound. This 
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phase is distinguished by the adsorption of proteins, release of cytokines and reactive 
oxygen species, and finally an arrival of inflammatory cells. Following the acute phase, 
a fibrous capsule is formed around the implant, inhibiting diffusion of glucose and 
oxygen into the sensor. Improving biocompatibility and increasing in vivo lifespan may 
be accomplished through prevention of protein adhesion or mediation of inflammatory 
response [76-78]. Yoshikawa et al. demonstrated that a nano-structured architecture of 
concentrated polymer brushes deters protein adhesion [79]. Gifford et al. demonstrated a 
reduction in the inflammatory response for glucose sensors that release nitric oxide [80].  
 Several CGM systems are currently commercially available for at-home use: 
Abbott’s Navigator 2 (not available in U.S.); Dexcom’s G4 Platinum; and several 
products from Medtronic, including the Guardian® REAL-Time CGM System [81-83]. 
Compared with earlier generations of these technologies, the latest CGM systems offer 
improved sensor and software performance to address issues of nonselectivity, oxygen 
dependence, and in vivo instability. These systems also aim to improve user experience 
and safety. Nevertheless, measurement of quality of life with CGM is similar to 
traditional glucose monitoring, likely due to the inconvenience of use (e.g., insertion of 
sensor). Furthermore, the sensors used in conjunction with these systems must be 
replaced every 6-7 days [76, 81]. 
 3.1.2.3 Nonelectrochemical glucose monitoring: The above glucose biosensors 
all rely upon an electrochemical reaction that suffers from consumption of glucose and 
the requirement that the sensor be in direct contact with the sample. Nonelectrochemical 
biosensors aim to address these problems by employing other techniques, such as optical 
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measurements [84]. For example, Aslan et al. employed a plasmon-based approach for 
glucose measurements. Dextran-coated gold colloids were aggregated through addition 
of concanavalin A (ConA); in the presence of glucose, plasmon changes were observed 
due to competitive binding between glucose and ConA, which disrupts the aggregates 
[85]. Alexeev et al. employed a crystalline array of colloidal particles within a hydrogel 
network with attached boronic acid recognition agents. Upon binding with glucose, these 
recognition agents cause a blueshift in the diffraction pattern that is representative of the 
glucose concentration. The change in color of the material, which will be incorporated 
into an ocular insert or contact lens, can be observed visually [86]. Malik et al. 
investigated the use of dual-wavelength polarimetry to measure glucose concentrations 
in the aqueous humor of the eye. The implementation of a second wavelength allows the 
authors to minimize noise in the system due to time-varying corneal birefringence [87]. 
Enejder et al. utilized Raman spectroscopy to transcutaneously measure blood glucose 
levels in individuals with heightened glucose levels. Using this technique, the authors 
obtained good calibration results, with a mean R2 value of 0.83 for the 17 subjects [88]. 
Robinson et al. measured glucose levels of the fingertip using transmission-based NIR 
spectroscopy. Viability of the technique was verified though a chemometric multivariate 
calibration method [89]. The above optical techniques aim to address some of the 
concerns of electrochemical methods by reducing the invasiveness of the measurement. 
However, none of these techniques has become commercially-available. Thus, there 
remains a need for a minimally-invasive, inexpensive, long-term blood analyte sensing 
system that takes advantage of the sensitivity of optical methods. 
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3.1.3 Encapsulation within RBCs 
 As an alternative, we propose that the sensing chemistry may be entrapped within 
RBCs using a hypotonic dilution method, as depicted in Figure 12. The cartoon 
illustrates the envisioned concept in which a small portion (e.g., 1 unit or less) of a 
patient’s blood would be removed, loaded with the analyte-sensitive fluorescent tag(s), 
and transfused back into the blood stream. This reintroduction process would be 
analogous to platelet donation, in which whole blood is removed, processed by a cell 
separating machine to remove platelets, and remaining components returned to the donor 
[90]. The resealed ghosts would then circulate for the remainder of the 120 day lifespan, 
reporting on analyte levels upon excitation by an external light source (e.g., laser diode). 
Rather than loading the entire distribution of RBC ages, it may be possible to 
preferentially load young RBCs, using one of many separation techniques based on cell 
density, cell size, surface charge, or osmotic fragility [91], and increase the circulation 
time of the sensors. While loaded, the fluorescent tag(s) would be shielded from the 
body, avoiding the immune response associated with many of the other long-term, in 
vivo sensors. Upon death of the loaded RBCs, it is expected that the fluorescent tag(s) 
would be filtered from the bloodstream. Although future work on the toxicity of the final 
fluorescent tag(s) must be completed, the FDA approval of indocyanine green for human 
use paves the way for in vivo application of other fluorescent dyes [92].  
 As proof-of-concept, the pH-sensitive, visible-wavelength dye, fluorescein 
isothiocyanate (FITC), was encapsulated within RBCs and used to monitor extracellular 
pH levels. This wavelength region is ideal for common fluorescence spectroscopy 
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equipment and microscopes, enabling straightforward data collection of fluorescence 
levels and visualization of the dye distribution within the resealed RBCs. The long-term 
goal, however, is encapsulation of an NIR, glucose-sensitive dye for the continuous 
monitoring of glucose for diabetic patients – a goal with broad-reaching implications. 
 
 
 
 
Figure 12. Cartoon illustrating the RBC sensing platform concept. A small portion of 
blood is removed from the patient; the blood is washed, loaded with the analyte-sensitive 
fluorescent dye, resealed, and then transfused back into the patient. An excitation light 
source is then directed at the wrist; the emission from the resealed red cell ghosts is 
collected and converted into an analyte concentration. Clip art used with permission 
from Microsoft. 
 
 
 
Efforts to entrap chemicals within RBCs began in the early 1950s with the 
successful encapsulation of ATP (as reviewed in [93]) and then, in 1959, various 
molecular weight dextrans [94]. In 1973, RBCs were first used as delivery vehicles for 
therapeutic agents by two independent groups [95, 96]. Since these early studies, the 
advantages of RBCs (e.g., biocompatibility, biodegradability, long life time) have 
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continued to drive the development of RBC carriers for delivery of biopharmaceuticals. 
Several excellent reviews on drug delivery using RBCs as biocompatible carriers are 
available [97-99].  
There are a number of ways in which to encapsulate substances within RBCs, 
which have been reviewed previously [93, 100-103]. Briefly, osmosis-based techniques 
include the hypotonic dilution, dialysis, and preswelling methods. The dilution technique 
is rapid and requires no special equipment, but the resulting resealed cells have lost a 
large proportion of their intracellular components, resulting in short circulation times in 
vivo. The latter two methods maintain near-normal Hb levels within the RBCs and may 
result in resealed cells with near-normal lifespans. The preswelling technique is simpler 
than the dialysis technique and shows higher entrapment efficiency. Other loading 
techniques include the osmotic pulse method (i.e., encapsulation of drug due to diffusion 
of DMSO), chemical perturbation (i.e., exposure to chemicals leading to irreversible 
damage), and electroporation (i.e., exposure of cells to an applied electric field to open 
pores and allow drug encapsulation). The electroporation method results in more 
uniform loading and long lifespans in circulation but requires specialized equipment. 
More recently, a novel means of encapsulation within RBCs delivered the load across 
the membrane using cell-penetrating peptides. Drugs were loaded into RBCs using 
carrier proteins to avoid the destructive characteristics, such as disruption of the 
membrane, of more traditional loading techniques [104, 105]. Using these methods, a 
multitude of drugs, including those based on amino acids, proteins, and enzymes, have 
been investigated for their use in RBC drug delivery systems. As an alternative 
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application, ICG-loaded RBCs were used to study the hemodynamics of the retinal 
capillaries and choriocapillaris [106]. However, prior to the work presented herein, 
resealed RBCs had not yet been explored, to the best of our knowledge, as a means of 
monitoring extracellular analyte levels within the blood. 
3.1.4 RBCs 
 RBCs are primarily responsible for carrying oxygen from the lungs to other 
tissues throughout the body via the bloodstream. When mature, RBCs lack a nucleus as 
well as many other cellular organelles considered vital for normal cellular function. As a 
result, RBCs can neither divide nor perform self-repair, such as the regeneration of 
damaged proteins [107]. Normal human RBCs are biconcave disk-shaped cells with an 
average diameter and thickness of 8 µm and 1.7 µm, respectively [108]. The average 
lifespan of an RBC is 120 days, after which the senescent RBCs are removed from the 
bloodstream by the reticuloendothelial system (i.e., spleen and liver), which sense 
damage to the RBC membrane and pit or remove the damaged areas [107].  
 A number of theories have been put forth to explain RBC senescence which have 
been summarized by Steinberg et al. [107]. The first theory relies on the loss of RBC 
membranes during the pitting process. Normal, biconcave RBCs have a volume of 90 fL 
and surface area of 140 µm2, a considerably higher surface area than is needed for a 
spherical particle of the same volume. However, the biconcave shape allows the RBCs to 
traverse through capillaries that are only one-third to one-half the diameter of the cell. 
Thus, if aging RBCs lose membrane material and become more spherical and rigid, it 
follows that these cells would have more difficulty traveling through the blood stream, 
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leading to cell death. A second theory postulates that RBC death is due to loss of 
enzymes responsible for maintaining the redox status of the cells. As a result, RBC lipids 
and proteins would become oxidized, leading to critical changes to the membrane, 
ultimately resulting in cell removal. A final theory proposes that RBC death results from 
an immune response. Normal oxidative damage has been shown to result in clustering of 
band 3 molecules, which are recognized and bound by an isoantibody, leading to 
removal by the reticuloendothelial system. 
 Hb is a 64 kD protein responsible for carrying oxygen to bodily tissues and is the 
major intracellular protein of RBCs. The role of RBCs, then, is to protectively package 
this vital protein, which would otherwise be rapidly excreted by the body in its free 
form. Hb is composed of four globular protein subunits; each subunit contains a heme 
group – a heterocyclic ring with an iron atom at its center that can carry a single oxygen 
molecule. Cooperativity among the four subunits leads to a sigmoidal oxygen 
dissociation curve. Essentially, the presence of each bound oxygen positively influences 
oxygen binding to the other subunits [107, 109]. A RBC will pass through the 
circulatory system approximately 105 times during its 120 day life span to carry oxygen 
to the tissues. The high surface area of the cell allows for a large area over which oxygen 
can diffuse out of the RBC into the tissues. In the body, Hb can present itself as 
oxyhemoglobin or deoxyhemoglobin, depending on whether the protein is saturated or 
desaturated with oxygen, respectively [108].  
 The RBC membrane, composed of lipids and proteins in equivalent weights, 
performs a number of important functions for operation and transport in the body [110]. 
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To perform its necessary tasks, the RBC membrane showcases a number of specialized 
characteristics, namely having elasticity and strength as well as a rapid response to fluid 
stresses. These abilities arise out of the membrane structure – a plasma membrane 
anchored to an elastic skeletal protein network [111]. The membrane is comprised of 
three layers: (1) the external layer, the glycocalyx, has a high concentration of 
carbohydrates; (2) the middle layer is a lipid bilayer with associated transmembrane 
proteins; and (3) the inner layer is a protein network known as the RBC membrane 
skeleton [112]. The lipid bilayer is composed, by weight, of equal parts cholesterol and 
phospholipids [111] and contributes to the permeability and fluidity of the membrane 
[110]. Proteins within the membrane skeleton, predominately spectrin, play a stabilizing 
and strengthening role in the membrane, providing a means for the membrane to deform 
through small capillaries and subsequently recover to a biconcave shape [112]. 
 The hypotonic dilution method mentioned above takes advantage of the RBC 
membrane’s ability to reversibly swell in response to the osmolarity of the extracellular 
environment [93, 113-115]. In this procedure, the RBCs are placed in a low osmolarity 
solution (i.e., lysis solution) at 0 °C, which causes the membranes to swell and develop 
pores that are estimated to range from 10 to 500 nm [93, 115-117]. While the pores are 
open, Hb and other molecules within the cell and fluorescent probes as well as salts in 
the lysis solution equilibrate. Once physiological osmolarity and temperature are 
restored, the pores reseal, entrapping the fluorescent probe. These carriers exhibit 
biodegradability and, as autologous cells, biocompatibility, thereby avoiding the 
deleterious effects of the immune system response [93, 98, 99, 115, 117, 118]. 
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Furthermore, resealed RBCs that have been returned to the body are able to circulate 
with a lifetime similar to normal RBCs [93, 113, 114, 119, 120]. Thus the sensors would 
have a lifetime of up to 120 days, depending upon the age of the RBCs at removal. 
 Furthermore, membrane proteins are responsible for important transport 
properties of the RBC membrane that lend themselves to biosensing. The existence of 
cell membrane transporters provide a route to report on extracellular analyte and ion 
levels by monitoring intracellular levels. Catecholamines – for example, dopamine, 
noradrenaline, and adrenaline – are a class of compounds transported across the 
membrane [121]. All mammalian RBC membranes contain the chloride-bicarbonate 
exchanger, one of several pathways for ion transport [122]. This transporter, which 
allows the intracellular pH to equilibrate to the extracellular level, is key to the proof-of-
concept work shown in this dissertation (i.e., the pH response of dye-loaded RBCs). 
RBC membranes of humans and other vitamin C-deficient mammals (e.g., primates and 
guinea pigs) also contain the Glut1 protein, which is responsible for rapidly transporting 
(i.e., seconds at body temperature [123]) and equilibrating glucose across the membrane 
[111, 124-127]. Future work targeting long-term glucose monitoring for diabetic patients 
relies upon this transport mechanism. Research on the effect of diabetes on the transport 
rates of Glut1 has not reached a consensus – some studies indicate an increased uptake 
[128] while others point to a decreased rate [129, 130]of glucose transport. Khera et. al 
demonstrated marked heterogeneity in the ratio of intra- to extracellular glucose levels 
among human RBCs [123] while Somogyi demonstrated no difference between the RBC 
to plasma glucose ratio of healthy and diabetic patients [131]. Although more research 
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would be needed for verification, these effects would likely not disrupt the ability of the 
proposed intracellular sensors to monitor extracellular blood glucose levels. Membrane 
transporters such as these allow for one to monitor intracellular analyte levels that are 
representative of extracellular levels – the characteristic exploited in the work presented 
in this dissertation. 
3.2 Materials and Methods 
3.2.1 Chemicals  
 Lysis solution components (MgCl2, EDTA, urea, and phosphate buffer), KCl, 
fluorescein 5(6)-isothiocyanate (FITC), glycylglycine, NaCl, and phosphate buffered 
saline (PBS) were purchased from Sigma Aldrich (St. Louis, MO). Anti-
fluorescein/Oregon Green, rabbit IgG was purchased from Invitrogen (Carlsbad, CA). 
Whole sheep blood in citrate was purchased from Hemostat Laboratories (Dixon, CA). 
FITC was reacted with 4.3-fold excess glycylglycine at pH 9 to form the glycylglycine-
FITC conjugate. All solutions were prepared with deionized water, adjusted to pH 7.4 
with HCl and NaOH, and stored at 4 °C.  
3.2.2 Preparation of Dye-Loaded, Resealed Red Cell Ghosts  
 In this preparation, RBCs are diluted approximately 10 times with a dye-
containing solution. The resulting RBCs are termed pink ghosts due to the low final 
concentration of entrapped Hb (i.e., 10% of original). Low Hb ghosts were used in these 
initial experiments as Hb absorbance overlaps with the emission of the fluorescent 
probe. However, future work will involve the incorporation of NIR fluorescent probes 
within high Hb ghosts, providing complete functionality of the RBC sensors in vivo.  
 45 
 
 Whole sheep blood was washed three times with 165 mM NaCl through 
centrifugation (10,000 x g, 3 min) to remove plasma proteins and leukocytes; washed, 
packed RBCs were stored on ice until loading. The lysis solution (53 mL) consisted of 
0.94 mM MgCl2, 1.9 mM EDTA, 4.7 mM KH2PO4, 1 M urea, 0.947 mM glycylglycine, 
and 217 μM glycylglycine-FITC conjugate. This solution was stirred in a beaker 
surrounded by a salt water/ice mixture to maintain the temperature at 0 °C for the 
loading procedure. Once the loading solution cooled to approximately 0 °C, 5 mL of 
packed RBCs were added in a single injection. After 10 min, 5 mL of 1.65 M KCl were 
added to restore osmolarity. After another 10 min, the ghosts were transferred to a water 
bath at 37 °C for 25 min to complete the resealing process. Free glycylglycine-FITC 
conjugate, Hb, residual leukocytes and RBC debris were removed via aspiration 
following three centrifugation cycles (10,000 x g, 8 min for first wash, 6 min for 
successive washes). Resealed ghosts not immediately used were stored at 4 °C in 5 
volumes of PBS. 
3.2.3 Sensor Response and Spectral Data Acquisition 
 For pH experiments, 100 mM NaOH and HCl solutions were prepared in 165 
mM NaCl to maintain the osmolarity of the local RBC environment. Resealed ghosts 
were added into room-temperature, isotonic NaCl until a sufficient fluorescence signal 
could be measured with the optical system. As approximately 90% of the Hb had been 
removed while making the resealed ghosts, 10 mM PBS was added to the resealed ghost 
solution to prevent large fluctuations in the extracellular pH.  
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 3.2.3.1 Optical system for dynamic data: A frequency doubled Ti:sapphire laser 
(approximately 15 mW, Mira 900, Coherent, Santa Clara, CA) served as the excitation 
source (λ ~440 nm) for the resealed ghosts (λex,max = 492 nm). A short-pass filter was 
placed just after the doubling crystal to remove remaining excitation light (880 nm). 
Fluorescence emission (λem,max = 518 nm) was collected at 90° with a spectrograph 
(Acton SpectraPro 2300i, Princeton Instruments, Trenton, NJ) attached to a CCD camera 
(PIXIS 100, Princeton Instruments, Trenton, NJ). For time-course measurements, the 
fluorescence signal was integrated over 500–570 nm. A pH probe (Orion 3 Star, Thermo 
Electron Corporation, Waltham, MA) was placed in the extracellular solution to 
simultaneously monitor extracellular pH throughout the entire experiment. All pH data 
was collected through HyperTerminal on the PC.  
 3.2.3.2 Optical system for static data: Fluorescence emission was collected with 
a fluorimeter (PTI, Birmingham, NJ) using an excitation wavelength of 488 nm. For 
time-course measurements, the fluorescence emission of a single wavelength (i.e., 514 
nm) was recorded for 20 to 30 sec. Extracellular pH of the experimental solution of 
resealed ghosts was continuously measured with the pH probe. Prior to data collection, 
anti-fluorescein antibody was added to the experimental solution to bind any free (i.e., 
extracellular) glycylglycine-FITC conjugate, quenching its contribution to the 
fluorescence signal. The fluorescence emission of a 1 mL sample of the experimental 
solution was recorded; the corresponding pH was recorded and the sample returned to 
the experimental solution. The pH of the experimental solution was adjusted, solution 
thoroughly mixed, and the measurements were repeated for several pH steps.  
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 For the emission spectra of free glycylglycine-FITC conjugate and resealed 
ghosts presented in this paper, the samples were excited using a 488 nm argon ion laser 
(model 163-M12, 25 mW, Spectra-Physics Lasers, Santa Clara, CA). Fluorescence 
intensity was collected using the spectrograph/CCD camera setup described in the 
dynamic data section.  
 3.2.3.3 In vivo data: All animal experiments received prior IACUC approval 
from the University of Missouri. Sprague-Dawley rats were administered isoflurane in 
conjunction with oxygen, which served as the anesthetic throughout the procedure. A 
catheter was placed in the femoral vein for injection of the dye-loaded ghosts or free 
dye. Hair in the vicinity of the optical probe location was shaved, and the optical probe 
was then secured in the proper location – in contact with the thigh tissue – for data 
collection throughout the experiment. In the first realization of the in vivo monitoring 
system, a white light source with a FITC excitation filter served as the excitation source 
for the loaded ghosts. Excitation was directed to the rat tissue through a standard 
bifurcated reflection probe (R400-7-UV-VIS, 6 illumination fibers around 1 collection 
fiber, Ocean Optics). Fluorescence emission was collected through the collection fiber, 
filtered with a FITC emission filter, and focused onto a spectrometer (USB-2000, Ocean 
Optics) operated with SpectraSuite software.  
 3.2.3.4 Testing of sensor integrity: To allow for comparison of intensity changes 
due to potential glycylglycine-FITC conjugate release, the fluorescence intensity value at 
514 nm was collected for 30 sec. The fluorescence contribution of extracellular 
glycylglycine-FITC conjugate was quenched by addition of an anti-fluorescein antibody. 
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After the experimental time period of 30 min, the intensity value at 514 nm was 
collected for an additional 30 sec. A second aliquot of the anti-fluorescein antibody was 
added and thoroughly mixed with the resealed ghosts. A third fluorescence time-based 
scan was recorded for 30 sec for comparison. 
3.3 Results and Discussion 
 Fluorescein has a pKa of 6.4, leading to pH-dependent fluorescence emission 
over the range of pH 5 to 9. For the experiments presented here, the fluorescein 
derivative, FITC, was conjugated to glycylglycine, rendering a cell impermeant 
compound—a requisite for stable encapsulation. The spectra of resealed ghosts and free 
glycylglycine-FITC conjugate (λex = 488 nm) are compared in Figure 13. Encapsulation 
of the fluorescent dye within the RBCs does not alter its emission curve. 
 
 
 
 
Figure 13. Comparison of fluorescence spectra of resealed ghosts (light blue) and free 
glycylglycine-FITC conjugate (dark blue) show that emission characteristics of the two 
solutions are nearly identical. 
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 To investigate the fluorescence intensity response to pH, acid or base was added 
in 1 to 5 μl aliquots to vary the pH of the resealed ghost environment between pH 6.5 
and 8.5. The resealed ghost solution was thoroughly mixed after each addition. For the 
dynamic data, the fluorescence intensity and pH signals were allowed to plateau prior to 
each acid/base addition to ensure that the resealed ghosts had sufficient time to 
equilibrate. The response time, defined as the length of time required for the signals to 
reach a steady state value, was typically less than one min. This response time most 
likely reflects the response time of the electronics and mixing time of the solution as the 
chloride-bicarbonate exchange system has a half time of less than 1 sec at 37 °C [132]. 
In the portion of the dynamic data shown in Figure 14, fluorescence intensity (integrated 
from 500 to 570 nm) tracks extracellular pH throughout the pH range of interest. The 
two curves exhibit similar characteristics in response to pH changes, including 
directionality, drift, and signal change for corresponding changes in pH values. The 
sensors demonstrate reversibility across the pH range throughout the 25 min of optical 
interrogation time (e.g., two pH measurements of approximately 7, separated by 9 
measurements over 16 min, had identical fluorescence intensity measurements within the 
experimental error of the system). This reversibility indicates that the optical system 
does not affect the membrane transporters or significantly photobleach the fluorescent 
probe. For the in vivo application of this sensor, the fluorescent probe would be subject 
to a significantly shorter excitation time (i.e., approximately 1 min, or the response time 
of the sensor), and since the RBCs mix during circulation through the body, one would 
not expect that the same resealed ghosts would be found within the excitation volume for 
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consecutive measurements. Thus, it is easy to envision that similar reversibility would be 
expected over the lifetime of the sensor. 
 
 
 
 
Figure 14. A representative portion of a pH trial performed on the dynamic system. 
Fluorescence intensity (light blue) of the intracellular pH-sensitive dye (FITC) tracks 
extracellular pH (dark blue). 
 
 
 
 The potential release of glycylglycine-FITC conjugate was investigated to 
evaluate the integrity of resealed ghosts over the experimental time period (i.e., 30 min). 
In repeated testing, the extent of the subsequent decrease in the measured fluorescence 
signal due to the first antibody addition varied between 9% and 46%. This variation in 
the signal contribution is directly related to how well the resealed ghosts are washed at 
the end of the preparation step (i.e., removal of free glycylglycine-FITC conjugate); 
more thorough washing will lead to a decrease in the measured contribution of free 
glycylglycine-FITC conjugate. Measured fluorescence intensities before and after the 
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second addition of anti-fluorescein antibody (after 30 min) were the same value within 
experimental error, indicating no significant amount of extracellular glycylglycine-FITC 
conjugate. Thus we assume the RBC membranes did not release glycylglycine-FITC 
conjugate during the pH experiments.  
 A pH trial performed on the static optical system is shown in Figure 15. After 
quenching of the extracellular glycylglycine-FITC conjugate fluorescence contribution, 
extracellular pH was monitored with the fluorescence-based sensors. After each pH 
change, the fluorescence signal at 514 nm was monitored for 30 sec to provide sufficient 
data to develop an average fluorescence signal at each pH; the pH was recorded for each 
pH step. This system shows similar reversibility as the dynamic system, indicating that 
this system does not negatively affect the RBC membranes. 
 
 
 
 
Figure 15. Fluorescence intensity responds to pH changes using the static system in which 
extracellular glycylglycine-FITC conjugate fluorescence is quenched by the anti-fluorescein 
antibody. Each segment is the middle 15 sec of a 30 sec fluorescence monitoring period. The 
grey lines indicate discontinuous data. The average pH is directly above each segment. 
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 After data collection, fluorescence intensity and corresponding pH values were 
selected for each signal plateau of the two pH trials (Figure 14 and Figure 15) to 
evaluate the sensor’s ability to monitor extracellular pH as a function of the measured 
fluorescence intensity (Figure 16). Both data sets were normalized at pH 7.4. The 
normalized sensitivity attained by the sensors was 0.44 per pH unit. For the dynamic 
system in Figure 14, the normalized standard deviation was 0.002, leading to a 
resolution, defined as the smallest change in pH discernible from the fluorescence 
intensity data, of 0.014 pH unit. For the static system in Figure 15, the normalized 
standard deviation was 0.0143, leading to a resolution of better than 0.1 pH unit. The 
decreased resolution of this system compared with the dynamic system is primarily 
attributed to electronic noise of the fluorimeter rather than to poor performance of the 
sensors since, for a sample of glycylglycine-FITC conjugate, the normalized standard 
deviation of the fluorimeter is 0.0149. The fluorescence intensity of the resealed ghosts 
shows a linear dependence between approximately pH 6.5 and 7.4. At higher pH values, 
the response becomes nonlinear, as expected for a dye with pK of approximately 6.4. 
From these data, the pKs for the two resealed ghost sets were determined to be 6.65 and 
6.59. These values vary slightly from the experimental pK of glycylglycine-FITC 
conjugate (pK 6.37), indicating that slight effects of the resealed ghost’s cytosolic 
environment may exist. However, the resealed ghosts clearly track changes in 
extracellular pH over the physiological range. 
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Figure 16. Normalized fluorescence intensity as a function of pH for the pH trials shown 
above in Figure 14 (○) and Figure 15 (●). The two trials agree well. Error bars represent 
one standard deviation. 
 
 
 
 The distribution of glycylglycine-FITC conjugate among the resealed ghosts was 
investigated through epifluorescence (λex = 488 nm, 60x objective) and bright-field 
phase microscopy (60x objective), as shown in Figure 17. Comparison of same field 
images of resealed ghosts taken with each of these techniques indicates that 
approximately 50% of the resealed ghosts contained the fluorescent dye (unloaded RBCs 
are not observable in the fluorescent micrograph). This observation matches well with 
observations of Bodemann et al. indicating that approximately 60% of ghosts made at 0 
°C reseal upon warming to 37 °C [133]. Across batches, entrapment efficiency, defined 
as the ratio of loaded, resealed ghosts to total RBCs, ranged from 30 – 80%. Although 
complete loading is ideal, it is not necessary for success of the sensor because (1) the 
fluorescence signal is an integration of all resealed ghosts within the excitation volume 
and (2) unloaded RBCs do not contribute to the background signal. The final sensor 
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design will include a reference fluorophore to account for variations in loading between 
batches, as well as in excitation and detection efficiencies. 
 
 
 
   
         (a)            (b) 
Figure 17. Representative (a) bright-field phase and (b) epifluorescence micrographs of 
resealed ghosts loaded with glycylglycine-FITC conjugate. (Scale bar represents 5 μm.) 
 
 
 
 Resealed ghosts loaded with glycylglycine-FITC conjugate were injected into a 
rat while monitoring the signal with a bifurcated reflectance probe. As shown in Figure 
18, each injection (noted with an arrow) resulted in a measurable increase in signal. For 
the 500 µL and 900 µL bolus injections of loaded ghosts, the fluorescence increased by 
0.72% and 1.03%, respectively. These measureable increases in signal were small, likely 
resulting from a host of reasons, the most significant of which are a suboptimal optical 
system as well as the considerable absorption and scattering of FITC fluorescence by 
tissue. Methods to circumvent these problems will be discussed in the next section. 
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Figure 18. Change in integrated signal upon injection of resealed ghosts loaded with 
glycylglycine-FITC conjugate into rat. Injections of 500 µL and 900 µL result in signal 
increases of 0.72% and 1.03%, respectively. 
 
 
 
3.4 Conclusions  
 RBCs offer a unique system for entrapping fluorescence-based sensing assays 
that protects the sensor from the damaging effects (e.g., biofouling) of the immune 
system. Furthermore, since normal RBCs live for 120 days, the red cell sensors have the 
potential to function for multiple months, significantly improving on current monitoring 
systems. In this work, we have shown that dye-loaded, resealed ghosts track changes in 
extracellular pH. Fluorescence intensity changes in response to pH were reversible, and 
the resealed ghost membranes were stable over the experimental time period. While it 
was shown that not all RBCs load during the procedure, complete loading, although a 
long-term goal, is not a requisite for success of this sensing system.  
 This platform technology offers the potential for a long-term, minimally-invasive 
method for monitoring blood analytes. Although the current system focuses on 
500 µl 
900 µl 
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monitoring pH, the pH-sensitive dye could be replaced with a dye that is sensitive to a 
different analyte of interest, such as glucose. Since human RBCs rapidly transport 
glucose across the membrane, we expect that intracellular levels would track 
extracellular levels, similarly to the pH work shown here. As highlighted by the results 
of preliminary in vivo work, there remains a need to design and optimize a RBC-based 
sensing system that is suitable for in vivo application. Aside from the development of a 
more sensitive optical system, areas for improvement include: (1) preparation of ghosts 
with near-normal Hb levels, thereby providing complete functionality in vivo; (2) 
incorporation of NIR dyes, where scattering and absorption of tissue/Hb are less 
significant, thereby increasing the excitation signal to the dye and emission signal to the 
detector, and (3) optimization of loading parameters to maximize loading homogeneity 
and efficiency, thereby maximizing the signal from the loaded ghosts. 
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4. APPLICATION OF PH-SENSITIVE NIR DYES TOWARDS THE APPLICATION 
OF IN VIVO BLOOD ANALYTE SENSING 
 
4.1 Background 
4.1.1 Benefits of the NIR Region for In Vivo Systems – Biological Basis 
 Shifting to the NIR region of the electromagnetic spectrum offers a number of 
unique advantages for in vivo spectroscopy. Fluorescence of endogenous molecules 
within tissue is dominant in the UV and visible range. Examples of major intracellular 
fluorophores (with excitation / emission wavelengths) in tissue include NADH (340 nm / 
460 nm), flavins (e.g., FAD; 450 nm / 525 nm), and aromatic amino acids (deep UV) 
[134]. The two major fluorophores in the extracellular matrix are the structural proteins 
elastin (340-370 nm / 400-450 nm) and collagen (280-300 nm / 350-400 nm) [1, 135]. 
The so-called tissue optical window [136], where absorption of biological tissue is low, 
is bound on the lower end by hemoglobin (both oxy- and deoxyhemoglobin) absorption 
and on the higher end by water absorption. As such, the wavelength range between 
approximately 650 and 950 nm, where light is able to penetrate several centimeters into 
tissue, is ideal for in vivo spectroscopy [137]. Within this wavelength region, tissue 
scattering dominates over absorption, with cell organelles such as nuclei and 
mitochondria serving as the main contributors [138]. Mie scatterers within tissue result 
in a scattering coefficient exhibiting little dependence on wavelength (i.e., λ-0.22) between 
600 and 2000 nm. However, the contribution of Rayleigh scattering resulting from 
collagen and elastin fibrils decreases as λ-4, resulting in an overall reduction in the total 
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reduced scattering coefficient (i.e., combined Rayleigh and Mie scattering) with 
increasing wavelength. The result of lower absorption and scattering in the NIR region is 
an increase in the optical penetration depth within the tissue [139].  
4.1.2 Benefits of the NIR Region for In Vivo Systems – Optical System Components 
 Aside from the role of tissue optical properties in the selection of fluorophore(s) 
for in vivo applications, advances in NIR technology have led to inexpensive and easily-
accessible optical equipment designed for use in the NIR, further easing the development 
of an optical system for interrogation of the NIR dye-loaded RBCs. Due to monetary 
constraints, a steady-state optical system was built to collect in vivo data for the NIR 
dye. Aside from relatively inexpensive optical components, other benefits of steady-state 
fluorescence include simplicity and small size of instrumentation leading to portability. 
However, in future iterations, it may be beneficial to move to a fluorescence lifetime-
based approach, which has the significant advantage of allowing the user to efficiently 
separate the fluorescence from the background signal and providing an absolute 
measurement. 
4.2 Materials and Methods 
4.2.1 Preswelling Method for Loading Glycylglycine-FITC Conjugate into RBCs 
RBCs were prepared for loading by washing whole bovine blood three times 
with 165 mM NaCl. The preswelling technique applied to loading glycylglycine-FITC 
conjugate is based on protocols of Tajerzadeh et al. and Pitt et al. [140, 141]. Eutonic 
K+-reversed Hank’s balanced salt solution (HBSS) was prepared as follows: 136.55 mM 
KCl, 0.73 mM KH2PO4, 15.15 mM NaHCO3, 5.41 mM NaCl, 0.56 mM Na2HPO4, and 
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11.10 mM glucose. To preswell the RBCs, 2 mL of 0.67x eutonic HBSS were added to 
0.5 mL of cleaned RBCs; the sample was gently mixed and centrifuged at 2200 g for 3 
min. The supernatant was discarded and 100 µL of hemolysate (equal volumes of RBCs 
and DI water to lyse the cells and provide extra intracellular components) was layered on 
top of the RBCs, followed by 100 µL volumes of glycylglycine-FITC conjugate. The 
RBCs were gently mixed and centrifuged following each addition of dye. Dye solution 
was added until the point of lysis, which is observed as a darkening of the supernatant 
and a loss of the distinction of the pellet layer. Osmolarity is restored and ghosts resealed 
by addition of 75-100 µL of 10x eutonic HBSS; resealed ghosts regain their bright red 
color. The resealed, loaded ghosts were annealed in a water bath at 37 °C for 30 min. To 
remove free glycylglycine-FITC conjugate, compromised membranes, and cytosolic 
components (e.g., hemoglobin), the resealed ghosts were washed 3-4 times with 165 mM 
NaCl. Unused ghosts were stored in PBS at 4 °C until use. 
For spectroscopic analysis, a 50 µL aliquot of the packed, loaded ghosts was 
thoroughly mixed with 2 mL of PBS in a cuvette. The dye was excited by a frequency-
doubled Ti:sapphire laser  (Mira 900, tunable from approximately 700 – 950 nm, 
Coherent) at 440 nm. Fluorescence emission from the sample was collected at 90° with a 
CCD camera-coupled spectrometer (Princeton Instruments, Acton 2300i) operated at a 
fixed temperature of -75 °C to minimize dark noise. 
4.2.2 NIR-Based Benchtop Spectroscopy System 
 For spectroscopic measurements, either a tunable Ti:sapphire laser (Mira 900, 
tunable from approximately 700 – 950 nm, Coherent) or a laser diode (785 nm, 80 mW, 
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M5-785-0080; 670 nm, 15 mW, HL6756MG; Thorlabs) was used as an excitation 
source for the NIR dyes in solution. Laser power was adjusted to 1 mW or less prior to 
the sample. Fluorescence emission from the sample was collected in the same manner 
described above. Scattered excitation light was removed through the use of a long-pass 
filter (Semrock, FF01-800/LP-25, 800 nm BrightLine LWP Edge Filter, 25 mm), which 
passed greater than 94% of light between 814 nm and 950 nm and less than 0.000014% 
at the appropriate laser wavelengths. 
4.2.3 NIR-Based Portable Optical System 
 To improve the accessibility of this optical system, a fiber optic probe-based 
portable optical system (Figure 19) was designed and built in-house. The final iteration 
consisted of a laser diode (785 nm, 80 mW, M5-785-0080; 670 nm, 15 mW, HL6756M; 
Thorlabs), trifurcated fiber probe (FCR-19IR200-2-ME, 200 µm cores, 0.22 NA, 
Avantes), and a pair of amplified silicon photodetectors (PDF10A, Thorlabs). These 
detectors exhibit high responsivity across the wavelength range of the NIR signal (i.e., 
800 – 950 nm), with peak responsivity at 960 nm. The laser diode, mounted in a TE-
cooled mount (LDM21, Thorlabs), was coupled into the excitation end (i.e., 17 
excitation fibers around 2 collection fibers) of a trifurcated fiber probe through the use of 
a mounted aspheric pair (C230260P-B, Thorlabs), which has a high NA (i.e., 0.55) lens 
to collect the highly divergent light from the laser diode coupled with a low NA (i.e., 
0.16) lens to couple the light into the fiber probe. Laser diode current and temperature 
were regulated via a laser diode driver (Model 505, 0 – 200 mA range, Newport) and 
benchtop temperature controller (TED200C, Thorlabs). Laser power at the output of the 
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fiber probe, measured with a digital optical power meter (PM100, console; S120UV, 
standard power sensor; Thorlabs), was controlled by changing the current to the laser 
diode and altering the coupling of the laser diode into the fiber probe. Power levels at the 
sample were typically maintained below 600 µW. 
 
 
 
 
Figure 19. Cartoon illustrating the basic setup of the portable optical system (figure not 
drawn to scale). 
 
 
 
Dye fluorescence was focused into each of two detectors by a second mounted 
aspheric lens (Thorlabs, 7.5 mm FL, A375TM-B). For ratiometric measurements, 
bandpass filters maximizing the percent change across the physiological pH range, 
determined via spectroscopic measurements, were employed prior to the collection lens. 
The optimal bandpass filter set was an 857 nm / 30 nm FWHM filter (Semrock, FF01-
857/30-25, BrightLine® single-band bandpass filter, 25 mm) and a 810 nm / 10 nm 
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FWHM filter (FBH810-10, 25 mm, Thorlabs). All filters had excellent rejection- and 
pass-band characteristics with greater than 98% transmission at the specified center 
wavelength and less than 0.0000363% transmission across the blocking regions 
important for the selected laser diodes. To maximize collected fluorescence, the 800 nm 
longpass filter used in the spectroscopy system discussed above was substituted for one 
of the bandpass filters.  
The output of each of the detectors was connected via BNC cable to a USB data 
acquisition system (USB-6009, 10 V maximum voltage, National Instruments). Voltage 
data from both channels were collected and visualized through a customized LabVIEW 
program (LabVIEW 2012, National Instruments). Raw data was written to a text file for 
subsequent off-line data analysis in MATLAB. A stand-alone application was built from 
the LabVIEW project for use on computers without LabVIEW software. 
4.2.4 In Vivo Experiments 
 All animal experiments were carried out at the University of Missouri following 
IACUC approval. Sprague-Dawley rats were administered isoflurane in conjunction with 
oxygen, which served as the anesthetic throughout the procedure. Catheters were placed 
in the jugular vein for injection of the dye-loaded ghosts or free dye and the carotid 
artery for removal of blood samples. Hair in the vicinity of the optical probe location 
was completely removed through shaving and subsequent application of Nair. The 
optical probe was then secured in the proper location – in contact with the thigh tissue – 
for data collection throughout the experiment. Excitation power at the end of the optical 
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probe was kept at approximately 500 μW, and experiments were conducted for a 
maximum of three hours. 
4.3 Results and Discussion 
4.3.1 Iteration 1, pH-Sensitive NIR Dye 
 Due to the myriad benefits of the NIR spectral range for in vivo 
applications, a pH-sensitive NIR dye based upon a cyanine dye was developed for 
incorporation into RBCs. The chemical structure of the first synthesized NIR dye, 
hereby termed NIR dye I, is shown in Figure 20. Cyanine dyes are characterized by a 
pair of nitrogen atoms separated by a polymethine chain, the length of which alters 
spectral properties [142]. By increasing the length of the polymethine chain, the 
absorption and emission of the dye can be extended into the NIR region. The nitrogen 
atoms are typically incorporated within heterocyclic aromatic rings, as demonstrated in 
the structure of NIR dye I. NIR dye I at 0.41 µM displayed excellent pH sensitivity as 
free dye in a 2:1 solution of 165 mM NaCl:PBS. As shown in Figure 21, the dye spectra 
display both intensity changes and spectral shifts as a function of pH. For low pH values, 
the higher energy peak at 830 nm dominates with little to no contribution from the lower 
energy peak at 880 nm. As pH increases, the 880 nm peak increases as the 830 nm peak 
decreases. The ratio of the intensities at 830 nm and 880 nm as a function of pH results 
in a calibration curve (Figure 21c) with a 67.17% change in signal over the range of pH 
6.5 to 7.3. Although the absorption and emission properties of NIR dye I were optimal 
for in vivo applications, the dye had a significant drawback – a predisposition for self-
association leading to aggregation. Both visual affirmation of dye inhomogeneity in 
 64 
 
solution and spectral effects served as manifestations of NIR dye I aggregation, a 
common problem associated with cyanine-based dyes. 
 
 
 
 
Figure 20. Chemical structure of NIR dye I developed for the in vivo realization of the 
dye-loaded RBC concept. pH sensitivity of the molecule is imparted by the 
methylpiperazine (indicated with green dashed line). 
 
 
 
 
 
Figure 21. (a) Raw and (b) normalized spectra of free NIR dye I [0.41 µm] in a 2:1 
solution of NaCl:PBS show the pH sensitivity of the dye. (c) Ratio of intensities at 830 
nm and 880 nm shows a 67.17% change in signal over the physiologically-relevant pH 
range of 6.5 to 7.3. 
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Figure 21 Continued. 
 
 
 
 Spectral characteristics of NIR dye I are similar to the cyanine dyes presented by 
Yarmoluk et al. [143] that had been developed for the detection of bovine serum 
albumin (BSA). In the presence of BSA, the spectral signal of the dye blue shifts and 
increases; importantly, fluorescence increased directly with BSA concentration. In this 
case, the tendency for aggregation and subsequent changes due to the presence of 
proteins were advantageous, as the changes served as indicators for protein 
concentration. Aggregation of these dyes in solution is caused by strong, attractive van 
der Waals forces between the dye molecules. Cyanine dye aggregates are known to 
exhibit different absorption and emission spectra than the monomeric form of the dye [7, 
143-145]. For the work presented here, the emission band of dye aggregates is 
bathchromically shifted compared with the monomeric form of the dye. The 
fluorescence intensity of aggregates in solution is low and tends to increase upon 
exposure to proteins, the interaction of which is believed to disrupt the aggregates.  
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 The protein binding characteristics of NIR dye I were tested via addition of BSA 
to a solution of the dye in PBS to maintain pH. For this experiment, approximately 42 
µM BSA was added to approximately 8 µM NIR dye I with stirring under constant 
excitation. As shown in Figure 22a and b, a number of representative spectra were 
chosen from a time-course experiment. Free dye in PBS displayed a single peak with a 
maximum at approximately 870 nm, presumably due to the presence of dye aggregates. 
Immediately following BSA addition, the dye spectrum displayed the onset of a blue 
shift, with an addition of a blue shoulder at 3.4 min. The dual peaks likely indicate the 
presence of both monomer dye molecules and aggregates. Over time, the monomeric 
fluorescence peak (i.e., the blue-shifted peak at approximately 835 nm) increased and 
narrowed while the aggregate peak disappeared. The integrated intensity increased 
approximately 11-fold due to the addition of BSA (Figure 22c). 
 
 
 
 
Figure 22. (a) Raw and (b) normalized spectra of NIR dye I display the fluorescence increase 
and the approximately 40 nm blue shift due to addition of 41.67 µM BSA to 8.24 µM NIR dye I 
in PBS. (c) Normalized integrated intensities show an 11-fold fluorescence increase. 
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Figure 22 Continued. 
 
 
 
Fluorescence increases were also observed when adding equivalent volumes of 
either membranes (i.e., white membrane sacks following removal of all intracellular 
components via lysing) or Hb (Figure 23). At the 30 min mark, integrated fluorescence 
displayed approximately 1.3-fold and 6.3-fold increases following addition of Hb and 
membranes, respectively. Although the signal increase had significantly slowed when 
the experiment was stopped at 30 min, data collection following an additional 30 min of 
incubation time showed that the signal saturated the detector at 10.46 V, indicating that 
the signal continued to increase at a slow rate. 
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Figure 23. Change in NIR dye I [24.7 µM] fluorescence signal upon addition of (a) Hb 
and (b) membranes. 
 
 
 
As one would expect the dye to interact with Hb once introduced into the RBCs 
via the loading procedure, the pH sensitivity of the NIR dye I:Hb complex was 
investigated similarly to that of the free dye. NIR dye I and Hb were allowed to incubate 
overnight to fully allow for the interaction to occur and reach steady state. As such, 
changes during the experiment should be due to changes in local pH rather than due to 
introduction of protein and disruption of aggregates. As expected from prior results with 
BSA, significant spectral changes were observed for the case of the NIR dye I:Hb 
complex (e.g., significant reduction in the longer wavelength peak). However, as shown 
in Figure 24, there are muted changes in both intensity and spectral shape as a function 
of pH. Although the calibration curve shows a pH-dependent trend (Figure 24c), the 
reduced pH-dependent changes in the longer wavelength peak negatively affect the pH 
sensitivity in that the total change in the normalized ratio between wavelengths 830 nm 
and 880 nm is approximately 21% across the range of pH 6.5 to 7.2. Due to significant 
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aggregation effects, dye loading within RBCs was unsuccessful, as the loaded cells 
could not be verifiably separated from aggregated dye. 
 
 
 
 
 
 
 
Figure 24. (a) Raw and (b) normalized spectra of the NIR dye I:Hb complex in a 2:1 
solution of NaCl:PBS show the pH sensitivity of the dye. (c) Ratio of intensities at 830 
nm and 880 nm shows a 21% change in signal between the physiologically-relevant 
range of pH 6.5 to 7.2, a muted response compared with the pH sensitivity of free NIR 
dye I. 
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 NIR dye I was shown to be solvatochromic, or sensitive to the polarity of the 
local environment. Upon increasing the ratio of ethanol to water (i.e., decreasing 
polarity), measured fluorescence of NIR dye I at 12.3 µM increased with a concomitant 
shift in peak wavelength and loss of the longer wavelength peak (Figure 25). This 
behavior is likely due to the presence of aggregates in polar solutions (i.e., water) [143]. 
Similar with the behavior of NIR dye I in the presence of proteins, the longer wavelength 
peak or shoulder (visible in the 0% and 20% ethanol samples) is attributable to dye 
aggregates, while the shorter wavelength peak represents monomeric dye. The dye 
demonstrated a hypsochromic shift, or blue shift, with increasing solvent polarity. The 
integrated intensity increased more than 100-fold from 0% to 90% EtOH. In a similar 
experiment, the blue color of the NIR dye I solution deepened significantly upon 
increasing ethanol concentration, as shown in Figure 26. The ethanol-to-water ratio 
experiment was repeated with the portable optical system. Due to the sensitivity of the 
detector, the fluorescence signal across a lower range of ethanol concentrations (i.e., 0-
25%) was collected. To ensure signal changes were in fact due to changes in 
fluorescence, the signals from the same ratios of ethanol to water samples without dye 
were also collected, which verified that the effect was in fact due to increased 
fluorescence. Figure 27 verifies the effect of increasing ethanol concentration on the 
fluorescence of NIR dye I at 9.3 µM that had previously been observed 
spectroscopically. At an ethanol concentration of 25%, the signal increased more than 
32-fold over the fluorescence of NIR dye I in pure water (i.e., 0% ethanol). These effects 
are consistent with those demonstrated by Berezin et al. [146]. Upon testing a number of 
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NIR dyes, the investigators demonstrated hypsochromic shifts of 8 – 30 nm in the 
spectrum with increasing solvent polarity. Furthermore, it was shown that the dyes 
exhibited higher fluorescence in methanol, ethanol, acetone, and DMSO than in water. 
 
 
 
 
Figure 25. (a) Normalized fluorescence spectra display the shift in spectrum as a 
function of ethanol concentration. (b) Greater than 100-fold increase in integrated 
fluorescence resulting from an increased ratio of ethanol to water. 
 
 
 
 
Figure 26. Deepening in color of NIR dye I [12.3 µM] sample is due to an increase in 
the ethanol to water ratio (i.e., samples 2 and 3 represent 0% and 50% ethanol). 
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Figure 27. Increasing ethanol concentration results in a greater than 32-fold increase in 
NIR dye I [9.34 µM] fluorescence.  
 
 
 
4.3.2 Iteration 2, pH-Sensitive NIR Dye 
To circumvent the problems associated with NIR dye I, a second pH-sensitive 
NIR dye, hereby termed NIR dye II, was synthesized. NIR dye II (Figure 28) is based on 
a poly-sulfonated IR-820, which was appended with a methyl piperazine (indicated with 
green dashed line) – the pH sensitive portion of the molecule. The presence of the 
sulfonate groups discourages stacking of the aromatic rings, decreasing the propensity of 
NIR dye II to aggregate in solution. As expected, NIR dye II was more stable than NIR 
dye I; for example, NIR dye II remained suspended in buffer. An absorption spectrum of 
NIR dye II is shown in Figure 29. 
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Figure 28. Chemical structure of NIR dye II highlights the addition of sulfonate groups 
compared with NIR dye I to reduce dye aggregation. 
 
 
 
 
Figure 29. Absorbance spectrum of NIR dye II [5 µM] in PBS. 
 
 
 
The pH sensitivity of NIR dye II was assessed with both the bench-top 
spectroscopy system and portable fiber-based system at two excitation wavelengths: (1) 
results from 670 nm excitation are shown in Figure 30 and Figure 32a; (2) results from 
785 nm excitation are shown in Figure 31 and Figure 32b. All samples consisted of dye 
diluted in PBS; pH adjustments were made with 1-2 µL aliquots of 100 mM NaOH and 
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HCl. When excited at 670 nm (within the shorter-wavelength peak of the absorbance 
spectrum, Figure 29), there is a slight blue shift of the fluorescence peak at 
approximately 830 nm and an increase in fluorescence of NIR dye II at 2 µM as the pH 
of the local environment is increased. When excited at 785 nm (within the longer-
wavelength shoulder of the absorbance spectrum, Figure 29), NIR dye II at 2.2 µM 
displays a slight blue shift with increasing pH similar to the shift exhibited upon 670 nm 
excitation. However, 785 nm excitation results in a decrease in the fluorescence peak 
upon increasing pH, counter to that shown for 670 nm excitation. The change in pH 
sensitivity based upon excitation wavelength results from the pH sensitivity of the dye 
absorbance. Upon increasing the pH of the sample, absorbance increases for the shorter-
wavelength peak and decreases for the longer-wavelength shoulder. 
 
 
 
 
 
Figure 30. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 670 nm 
excitation source and bench-top spectroscopy system. Representative (a) raw and (b) 
normalized spectra as a function of pH. 
 
pH 
increase
pH 
pH 
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For data analysis and comparison with the portable system, the spectral bands 
corresponding to the selected filters of the portable system were used for a ratiometric 
measurement of pH changes. In this case, the bands were a 10 nm FWHM bandpass 
filter at 810 nm and a 30 nm FWHM bandpass filter at 857 nm. The ratios of the two 
bands at different pH levels were used to develop calibration curves for each excitation 
wavelength. As shown in Figure 32, the dye exhibits increases of 16.34% and 29.42% 
for 670 nm and 785 nm excitation, respectively, across the physiologically-relevant 
range of approximately pH 6.85 to 7.5. 
 
 
 
pH 
increase 
pH 
increase 
Figure 31. pH sensitivity of 2.2 µM NIR dye II in PBS as measured with a 785 nm 
excitation source and bench-top spectroscopy system. (a) Raw and (b) normalized 
spectra as a function of pH.  
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Figure 32. Calibration curves for (a) 670 nm excitation and (b) 785 nm excitation show 
increases in the ratio of 16.34% and 29.42% across pH 6.85 to 7.5, respectively. 
 
 
 
For analysis with the portable system, pH measurements and voltage 
measurements corresponding to both bands were collected simultaneously. As shown by 
the time-course data in Figure 33b and Figure 34b, pH and the ratio of the two spectral 
bands track well. When the ratio is plotted as a function of pH, the resulting calibration 
curves (Figure 33a and Figure 34a) for the two excitation wavelengths strongly resemble 
those obtained using spectroscopic measurements (Figure 32). The calibration curves 
show increases of 14.86% and 31.67% between pH 6.85 and 7.5 for 670 nm and 785 nm 
excitations, respectively. Although a strong pH-dependent trend is present, the total 
change in signal over the physiologically-relevant range (i.e., pH 6.85 to 7.5) is small – 
less than approximately 30% for both excitations. Thus, small pH changes achievable in 
vivo by CO2 inhalation (decrease pH) or sodium bicarbonate injection (increase pH) may 
be undetectable with NIR dye II. 
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Figure 33. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 670 nm 
excitation source and portable, fiber-based optical system. (a) Calibration curve shows 
an increase in the ratio of 14.86% across approximately pH 6.85 to 7.5. (b) Time-course 
measurements of pH and ratio show that the two variables track each other well. 
 
 
 
 
 
 
 
Aside from the measured spectral changes, the color of NIR dye II sample 
changes as a function of pH, as easily seen for a representative high concentration 
Figure 34. pH sensitivity of 2 µM NIR dye II in PBS as measured with a 785 nm 
excitation source and portable, fiber-based optical system. (a) Calibration curve shows 
an increase in the ratio of 31.67% across pH 6.85 to 7.5. (b) Time-course measurements 
of pH and ratio show that the two variables track each other well. 
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sample (Figure 35). At high pH levels, the sample has a strong blue hue (Figure 35a), 
which is lost upon lowering the pH (Figure 35b).  
 
 
 
 
Figure 35. The effect of pH on NIR dye II can be observed via the difference in color of 
a 20 µM NIR dye II sample at (a) high and (b) low pH levels. 
 
 
 
To test the pH sensitivity of NIR dye II in an environment closer to that expected 
in the in vivo realization of the system, the dye was loaded into bovine RBCs with a final 
lysis solution concentration of 20 μM free dye using the method described previously. 
Spectral measurements (785 nm excitation) were recorded as pH of the local 
environment was adjusted from pH 8 to 6.46. As shown in Figure 36, the dye 
fluorescence exhibits a slight blue shift and decrease as the pH increases. The ratio of the 
810 nm band to 857 nm band shows a similar shape to that of the free dye in PBS. 
However, over the physiological range of pH 6.82 to 7.51, the dye-loaded cells show an 
increase in ratio of only 13.24%, a muted response compared with free dye. This 
difference may be due to some residual aggregation effects, as seen with the Hb binding 
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pH curve for NIR dye I. Thus, the change in signal over the physiological range is small 
and further verifies that it may be impossible to detect in the more complicated in vivo 
environment. 
 
 
 
 
Figure 36. pH sensitivity of NIR dye II-loaded bovine cells as measured with a 785 nm 
excitation source and bench-top spectroscopy system. (a) Raw and (b) normalized 
spectra show fluorescence decrease and blue shift with increasing pH. (c) Calibration 
curve shows an increase in the ratio of 13.24% over the physiological range of pH 6.82 
to 7.51. 
 
pH 
increase 
pH 
increase 
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4.3.3 In Vivo Implementation of NIR Dye II 
As mentioned previously, the synthesized NIR dyes do not possess sufficiently 
high pH sensitivity for reliable in vivo monitoring in the current embodiment of the 
system. Furthermore, preliminary results using inhalation of CO2 and injection of 
sodium bicarbonate did not result in any measurable changes in signal. Thus, the ability 
to visualize both free and loaded NIR dye II within an animal with the in-house built 
portable fiber-probe system was investigated.  
A calibration curve of signal voltage as a function of dye concentration within 
the blood volume of the animal was produced following bolus injections of free NIR dye 
II. Bolus injections of 375, 150, 75, and 25 µL sample volumes of 400 µM dye were 
injected into the jugular vein of the rat while optically monitoring the vascularized leg 
tissue above the femoral vein. Assuming a 15 mL blood volume, these dye volumes 
resulted in concentrations within the vasculature between 0.67 and 10 µM. The 
calibration curve (Figure 37b) can be fit to a linear trendline with R2 greater than 0.99. 
Combining the free dye data across five animals, a second calibration curve can be 
produced, as shown in Figure 38. This curve shows more variability, as expected across 
multiple animals, but follows a similar trend to that shown in the single-animal curve. 
The data follow a trendline with an R2 value of approximately 0.95. The variability can 
be attributed to dye clearance and other physiological differences among the animals. As 
shown in Figure 37a, the measured signal begins to rapidly increase upon injection, 
reaching a maximum level approximately 5 min post-injection. After approximately 1 
min at the peak level, the signal begins to slowly decay, likely resulting from removal of 
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the free dye via filtration of the kidneys and sequestration in the bladder. The decay 
kinetics follow a custom equation — 𝑓(𝑥) = 𝑎 ∙ 𝑒𝑥𝑝(−𝑏 ∙ 𝑥) + 𝑐 — with R2 values for 
the fits greater than 0.99. For three trials, the average time constant of the decay mode 
for free dye was 18.51±2.40 min. 
 
 
 
 
 
Figure 37. Bolus injections of free NIR dye II lead to rapid increases (approximately 5 
min to peak value) in measured signal followed by a slower decrease in signal, likely 
due to dye removal from the bloodstream. The data can be fit with a linear trendline (y = 
0.6762x – 0.4801) with R2 greater than 0.99. 
 
 
 
 Using the dilution loading technique discussed previously, washed, packed horse 
RBCs were loaded with 132.7 µM NIR dye II. Following the procedure, the loaded 
ghosts were washed three times and pelleted as preparation for injection into the rat. 
During this preparation, it was noted that some loaded ghost samples appeared darker 
than others. In an attempt to elucidate an explanation for the discrepancies, the loaded 
ghosts were centrifuged in small diameter tubes to separate different sections within the 
samples.  
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Figure 38. Voltage increase as a function of dye concentration within the blood for data 
taken across five different animals. The data can be fit with a linear trendline (y = 
0.5749x – 0.4149) with R2 ≈ 0.95. 
 
 
 
 As shown in Figure 39, three types of samples were prepared using an identical 
loading procedure over the course of a week for in vivo studies. The differences 
observed among the prepared samples point to a significant difficulty with the current 
loading process. Using experience and microscopy, the different layers – between 4 and 
5, depending on the sample – were identified, as shown in Figure 39c. All prepared 
samples had a large layer of supernatant (i.e., residual Hb and free dye) and a thin, 
diffuse layer composed of ruptured membranes (most obvious in Figure 39c) that are no 
longer associated with Hb or dye (i.e., they appear colorless). As shown in Figure 39c, 
some samples contained a dark blue layer immediately below the white layer. This dark 
layer, which is only present in some of the samples, is likely formed from dye aggregates 
that are associated with membranes or other cell components. As confirmation, cells or 
cell-like material were not visible in microscopy images.  
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Figure 39. Examples of three different samples of NIR dye II-loaded ghosts obtained 
using an identical loading procedure. The differences observed among the samples 
points to problems inherent to the loading procedure. Samples shown in (a) and (b) 
contain 4 layers while the sample in (c) contains 5 distinct layers. 
supernatant 
membranes 
dye aggregates 
ghosts 
RBCs 
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The next layer, visible in all samples, is a light red layer, which is believed to be 
the loaded ghosts. As expected by the procedure, these cells contain only a portion (i.e., 
10%) of their Hb, which results in lighter cells as compared with the control RBCs. As 
shown in Figure 40 and Figure 41, microscopy confirmed the presence of cells within 
the light red layer. Due to the long excitation wavelength required, standard fluorescence 
microscopes cannot excite and collect the emission from NIR dye II. As such, a 
derivative of the dye with shorter wavelength excitation and emission was loaded within 
horse ghosts following the same procedure. Approximately 20% of the processed ghosts 
were loaded with the dye derivative. Alternatively, NIR dye II was loaded within bovine 
ghosts and imaged using an inverted microscope (FV1000, Olympus America) fitted 
with an IR800 filter cube. Emission was coupled to a CCD camera for imaging, and data 
was collected with Micro-Manager Software [147]. An example overlay of bright-field 
and fluorescence images (Figure 41) shows that approximately 35% of the cells were 
loaded with dye. Out of focus fluorescence is due to loaded ghosts at other focal planes 
as well as moving ghosts that were not fully adhered to the cover slide. 
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Figure 40. Overlay of DIC and fluorescence micrographs of (a) NIR dye II-loaded horse 
ghosts and (b) the shorter wavelength dye derivative-loaded horse ghosts. Use of a 
shorter wavelength dye allows for visualization of fluorescence from dye-loaded ghosts. 
Approximately 20% of the ghosts have been successfully loaded with dye. 
 
 
 
 
Figure 41. Overlay of bright-field and fluorescence micrographs of NIR dye II-loaded 
bovine ghosts show that approximately 35% of the ghosts were successfully loaded with 
dye. 
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The bottom layer, most significant in Figure 39b, is likely RBCs that did not lyse 
during the loading procedure, and therefore, these cells contain normal amounts of Hb 
and weigh more than the loaded ghosts, dye aggregates, and ruptured membranes. It 
should be noted that injection of this bottom layer as well as control horse RBCs did not 
result in any change of the optical signal. However, both the light red layer and dark blue 
layer resulted in an increase in the measured optical signal. The red region was carefully 
isolated from the remaining layers using a thin needle and syringe and diluted 50% with 
PBS in preparation for injection. Once a steady baseline signal was achieved, the red 
layer was injected into the jugular vein of the sedated rat. As shown in Figure 42, the 
measured signal increased upon injection of the sample, reaching a maximum level in 
less than 10 min. The signal then decreased following a curve described by the sum of a 
single exponential and constant (i.e., the same fit as for free dye). The graphs in Figure 
42a and b are sample curves obtained by injection of 200 µL and 830 µL, respectively, 
volumes of the light red portion of two different loaded ghost samples. For three trials 
using different samples, the average time constant of the decay mode for NIR dye II-
loaded ghosts was 28.65±18.28 min. Results of the time constants from both free dye 
and loaded ghosts are summarized in Table 3. 
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Figure 42. Bolus injections of NIR dye II loaded within horse RBCs using a dilution 
technique. (a) and (b) are representative of two different samples within different rats. 
 
 
 
Table 3. Time constants for signal decay of free dye and dye-loaded ghosts following 
injection into a rat. 
  Time Constant (min)       
Free dye 
19.07    
20.58  Avg: 18.51 min 
15.88   St. Dev: 2.40 min 
Red Region 
14.86     
49.38  Avg: 28.65 min 
21.70   St. Dev: 18.28 min 
 
 
 
Although there is not a statistical difference between the time constants of the 
free dye and loaded ghost samples, this preliminary data indicates that there may be 
some difference in the removal rates of the samples that may be optimized and verified 
upon further work. There are several theories that may explain the rapid removal of the 
ghost samples from the animal. First, loading horse RBCs, even unmodified, into a rat 
may result in unexpected problems, as horse RBCs possess different surface properties 
and may be rapidly removed. Baskurt et al. compared the aggregation tendencies of rat 
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and horse RBCs by studying their sedimentation rates [148]. Horse RBCs showed 10-
fold and 18-fold increases in aggregation compared with rat RBCs at stasis and under 
shear stress, respectively. Rat RBCs were shown to exhibit a higher surface charge than 
horse RBCs. Finally, SDS-PAGE analysis showed differences in the distribution of 
carbohydrate-rich proteins and the absence of a band related to a particular membrane 
protein in horse RBCs. Lawrence et al. have shown that RBCs modified via chemical 
alteration of the membrane or coating with an antibody were rapidly removed from the 
circulatory system [149]. In normal subjects, the clearance times for chemically-
modified and antibody-coated RBCs were 15.8 and 57.6 min, respectively. These times 
are in line with the data collected using NIR dye II-loaded ghosts.  
A second problem that may be contributing to the signal decay may result from 
the procedure used to load the dye within the ghosts. It has been shown that cells that 
have had a majority of their Hb and other cellular components removed are rapidly 
removed from the body by the reticuloendothelial system [93]. As such, it may be 
necessary for the long-term goals of this project to load the fluorescent dye within the 
RBCs using a technique that maintains near-normal levels of Hb, which will likely result 
in longer circulation times in vivo. Through optimization of the procedure, it may be 
possible to produce loaded cells with near-normal lifespans once reintroduced [93].  
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Preliminary results, as shown in Figure 43, for loading glycylglycine-FITC 
conjugate using the preswelling technique (i.e., one of two common high Hb techniques 
used to load within RBCs) are promising that dye may be loaded into RBCs while 
maintaining their Hb at near-normal levels. However, as expected from the strong 
absorbance of Hb as well as increased scattering at wavelengths in the visible region of 
the spectrum, the fluorescence spectra of free and loaded glycylglycine-FITC conjugate 
are significantly different (Figure 43a). The locations of the strong absorbance bands of 
Hb are indicated on the fluorescence spectrum by the shaded blocks. The dips in the 
FITC fluorescence correspond well with the absorption peaks of oxygenated Hb. Lysing 
the cells via addition of water reduces the scattering of the samples and allows the 
encapsulated glycylglycine-FITC conjugate to diffuse into the entire sample volume. 
Upon lysis, the measured fluorescence increases greater than 8-fold. Conversely, the 
signal increase due to dilution alone, verified by adding an equivalent volume of 165 
mM NaCl rather than water, is less than 1.5-fold. This further verifies the destructive 
effects of blood (i.e., Hb absorbance and scattering) on the fluorescence of dyes that emit 
in the visible wavelength range, confirming the need to move to the NIR. 
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Figure 43. (a) Difference between the fluorescence spectra of a solution of free 
glycylglycine-FITC conjugate (dark green) and glycylglycine-FITC conjugate loaded 
within high Hb bovine ghosts (light green). Shaded areas represent the two absorption 
peaks of the oxygenated Hb spectrum. (b) Greater than 8x increase in signal upon lysing 
the loaded cells (light blue) with water, which releases the glycylglycine-FITC conjugate 
loaded within the cells. Less than 1.5x signal increase results from an equivalent dilution 
with 165 mM NaCl, which does not lyse the cells. 
 
 
 
 The animal specific and animal nonspecific calibration curves shown in Figure 
37 and Figure 38, respectively, were used to determine the equivalent concentration of 
dye within the animal given the measured voltage increases for the loaded ghost 
injections of 200 µL and 830 µL. As summarized in Table 4, the measured voltage 
increases are equivalent to approximately 2.05 µM and 2.29 µM (200 µL injection 
leading to 0.9038 V increase) and 4.93 and 5.69 µM (830 µL injection leading to 2.8552 
V increase) dye concentrations in the rat vasculature. If we consider the packed cell 
volume (i.e., half of the total injected volume) to be dye at the concentration loaded 
within the ghosts (i.e., 132.7 µM), the maximum achievable dye concentration in the 
blood due to the 200 µL and 800 µL injections would be 0.88 µM and 3.67 µM, 
respectively. These concentrations are lower than would be expected from the 
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calibration curves given the voltage increases achieved with loaded ghosts. Given that 
only approximately 20 – 30% of the ghosts were successfully loaded with dye supports 
the position that assuming 100% dye volume in the ghost sample is a far larger volume 
than injected (i.e., this assumption assumes perfect packing with no space between cells, 
the membranes comprise no volume, and all cells loaded perfectly). Closer estimates of 
the equivalent free dye concentration within the rat would be an order of magnitude 
lower. This discrepancy in the measured signal indicates that the loaded ghosts were 
different than free dye and that loading within the ghosts may result in an enhancement 
of the signal. 
 
 
 
Table 4. Effective concentrations of loaded ghosts within rat compared with maximum 
concentration achievable assuming free dye. 
 
Effective 
concentration using 
animal-specific 
calibration curve 
Effective 
concentration using 
animal-nonspecific 
calibration curve 
Concentration 
assuming packed 
volume (½ total) to 
be 132.7 µM dye 
200 µL injection, 
132.7 µM 
2.05 µM 2.29 µM 0.88 µM 
830 µL injection, 
132.7 µM 
4.93 µM 5.69 µM 3.67 µM 
 
 
 
The fluorescence properties of NIR dye II were also sensitive to changes in both 
temperature and concentration, which is highlighted in Figure 44. NIR dye II samples 
ranging from 1 µM to 20 µM were prepared and temperatures lowered to approximately 
4 °C. Spectral data was collected as the samples warmed to room temperature. As shown 
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by the representative low concentration (5 µM; Figure 44a and b) and high concentration 
(20 µM; Figure 44c and d) samples, fluorescence is minimized for all concentrations at 
low temperature. Quenching is more significant at higher concentrations, as the increase 
in total integrated fluorescence is 20.35% and 422.9% for the 5 µM and 20 µM samples, 
respectively. Furthermore, at low temperatures, the high concentration samples exhibit a 
slight blue shift of the 830 nm peak and introduction of a longer wavelength peak at 910 
nm. As temperature increases, the longer wavelength peak decreases, supporting the 
hypothesis that these spectral effects result from low temperature aggregation of the dye 
molecules. This also supports the presence of the dye aggregate layer observed in some 
NIR dye II-loaded ghost samples. An image of the samples ranging from 20 µM 
(leftmost) to 1 µM (rightmost) are shown in Figure 45 at (a) approximately 4 °C and (b) 
room temperature. Lower concentration samples (i.e., 1 or 2 µM) remain clear regardless 
of temperature. However, higher concentration samples (i.e., 5 to 20 µM) are clear at 
approximately 4 °C and develop a blue tint, which is concentration dependent, with 
increased temperature. Thus, temperature effects are more significant for high 
concentration NIR dye II samples, pointing to dye aggregation as the culprit.  
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Figure 44. (a) Raw and (b) normalized fluorescence spectra of 5 µM NIR dye II as a 
function of temperature show a 20.35% increase in integrated signal with increased 
temperature from 4 °C to room temperature. (c) Raw and (d) normalized fluorescence 
spectra of 20 µM NIR dye II as a function of temperature show significant spectral 
changes and a 422.9% increase in integrated signal with increased temperature. Note: 
line colors darken with temperature. 
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Figure 45. NIR dye II samples are displayed from high to low concentration (left to 
right) at (a) 4 °C and (b) room temperature. Blue color of the high concentration (i.e., 5 
µM and higher) samples develops as temperature increases. 
 
 
 
4.4 Conclusions 
The NIR region of the electromagnetic spectrum is ideal for in vivo applications, 
as this region provides the lowest levels of absorption (i.e., due to Hb and water) and 
scattering. As such, penetration depth within tissue is higher compared with dyes that 
emit in the visible region of the spectrum. Although absorbing and emitting in the 
correct portion of the spectrum, the NIR dyes synthesized as a part of this work had a 
number of unintended difficulties. NIR dye I was very sensitive to both solvent polarity 
and presence of protein. Due to a strong tendency to aggregate, this dye was not 
applicable for loading within RBCs. NIR dye II was modified to discourage aggregation 
and proved to be much more stable in solution. However, the pH sensitivity of the dye 
over a physiologically-relevant range was too low for reliable use in vivo, precluding the 
ability to optically monitor pH within the animal. Nonetheless, the enhanced sensitivity 
of the optical system and increased collection of fluorescence due to the NIR wavelength 
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region allowed for relatively large increases in signal to be measured upon injection of 
both free and loaded NIR dye II. Both free and loaded dye reached maximum signal 
levels approximately 5 min post-injection, after which both signals decayed following 
the sum of a single exponential and constant. Encapsulation within the ghosts resulted in 
enhanced signal levels following injection compared with the expected signal increase 
due to free dye. Thus, although encapsulation did not result in significantly longer 
circulation times in vivo, the enhancement in signal observed for injected ghosts verified 
that these samples were, in fact, different than free dye. Employing autologous RBCs, 
rather than cross-species RBCs, will avoid issues related to host response and likely 
result in prolonged circulation time of dye-loaded cells in vivo. 
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5. CONCLUSIONS 
 
5.1 ZnO Nano/microstructures as Environmental Sensors 
In this work, ZnO nano- and microstructures across three size regimes (i.e., 0-D, 
1-D, and 2-D) were assessed for photobleaching rates under continuous and periodic 
excitation. The rate of photobleaching was shown to be a function of the surface area to 
volume ratio with higher ratios leading to increased photobleaching. This finding 
indicates that reactivity of the nano/microstructures relates to the surface states, which 
comprise a higher ratio of states for very small particles with high surface area to volume 
ratios. ZnO nanoparticles, which exhibited high sensitivity to changes in the 
environment, also exhibited high sensitivity to humidity – a promising result for future 
work towards a generalized ZnO nanoparticle sensor platform. The nanoparticles 
displayed a linear response with sensitivities of 0.65% change in signal per % RH 
(normalized sensitivity of 0.008417 RH-1) and 0.75% change in signal per % RH 
(normalized sensitivity of 0.01898 RH-1) in nitrogen and air, respectively. 
In future work, ZnO nanoparticles may be applied to more clinically-relevant 
gases, such as CO or NO2. NO2 has been implicated as a contributor to air pollution, a 
recognized health problem. Proper monitoring of the gas with an inexpensive sensor 
such as one built on a ZnO platform is an important step in solving this global crisis and 
reducing the associated health problems. 
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5.2 RBC-Based Monitoring of Blood Analytes 
We have shown that carrier RBCs, which have been traditionally applied towards 
drug delivery, can be loaded with analyte-sensitive intracellular dyes. Using simple 
optical techniques, these dyes then report on changes in extracellular analyte levels – the 
first demonstration of these carrier cells towards long-term blood analyte monitoring. 
 RBCs loaded with a glycylglycine-FITC conjugate using the dilution technique 
were shown to reversibly monitor extracellular pH changes. These ghosts have low Hb 
levels, which has important implications for the emission region of the dye. The 
emission of FITC between 500 and 600 nm overlaps with strong Hb absorption; 
furthermore, scattering is significant in this region of the spectrum. The drawback of this 
method, however, is that these cells will likely be rapidly removed from the circulation 
due to their low levels of Hb and other intracellular components. Preliminary results 
using a loading procedure that maintains near-normal levels of Hb suffered from 
significant decreases in FITC emission due to scattering and absorbance, as highlighted 
by the large spectral changes.  
For the in vivo realization of this sensing platform, it is necessary to move into 
the NIR region, where absorbance and scattering of tissue are minimized. Two NIR 
emitting dyes were prepared and tested for their pH sensitivity. NIR dye I displayed 
significant aggregation effects in solution due to self-association of the molecules. 
Furthermore, its spectrum shifted based on polarity, and the fluorescence was much 
higher in ethanol than in water. The fluorescence also increased upon binding with 
proteins, likely due to disruption of the aggregates. Finally, pH sensitivity of protein-
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bound dye was shown to be significantly less than that of free dye. NIR dye II had 
additional sulfonate groups to reduce aggregation. However, the dye was shown to be 
temperature sensitive, owing to aggregation at low temperatures.  
NIR dye II as a free and loaded dye showed pH changes of approximately 15 – 
30% and 13%, respectively. These changes were too small to reliably track the small pH 
changes manageable by adjustments using sodium bicarbonate and CO2 in vivo. 
Nevertheless, the signal from dye-loaded ghosts was easily monitored with a fiber optic 
probe-based system. Although the circulation times of free and loaded dye were not 
statistically significantly different, the signal levels from loaded dye were higher than 
expected for free dye. The enhancement effect may be due to binding of the dye with 
protein, as seen with NIR dye I.  
The circulation time of dye-loaded RBCs in vivo may be lengthened through a 
number of measures. First, it may be beneficial to load autologous or homologous RBCs 
rather than cross-species RBCs. The first step may be tracking of control horse RBCs 
following injection into a rat. Determining the circulation time of these cells may give 
insight into the maximum time that dye-loaded horse RBCs may be expected to survive 
in a rat. Given the significant differences between horse and rat RBCs, this circulation 
time may be lower than initially predicted. Second, the use of a gentler loading method 
(e.g., dialysis or preswelling) that maintains near-normal levels of Hb and other cellular 
components may aid in maintaining near-normal lifespans of RBCs following injection. 
These methods rely on limiting the volume into which the RBCs are placed for the lysis 
procedure; the methods also require a smaller volume of analyte-sensitive dye to obtain 
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equivalent loaded concentrations. Alternatively, a different labeling mechanism, such as 
one recently published that relies on modification of RBC progenitor cells, may be used 
for preparation of RBCs for long-term monitoring [150]. The modification process did 
not damage the membranes, and in vivo survival studies showed little difference in the 
circulation times of control and modified RBCs in a mouse. The synthesis of a two-band 
ratiometric, highly pH- or glucose-sensitive NIR dye is necessary for verifying the use of 
this system for in vivo blood analyte monitoring. Although monitoring pH is clinically 
relevant for many patients, long-term, minimally-invasive glucose monitoring is 
paramount given the already high and still growing incidence of diabetes. 
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